Omnicomm Systems (OMCM) 10-K 28 Mar 19 2018 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2018	Mar. 26, 2019	Jun. 30, 2018
Document Information [Line Items]
Entity Registrant Name	OMNICOMM SYSTEMS INC
Entity Central Index Key	0001034592
Trading Symbol	omcm
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		158,278,341
Entity Public Float			$ 26,073,963
Entity Shell Company	false
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
CURRENT ASSETS
Cash	$ 1,440,524	$ 1,176,551
Accounts receivable, net of allowance for doubtful accounts of $176,220 and $149,980, respectively	6,175,277	7,492,597
Prepaid expenses	384,212	297,131
Other current assets	5,204	11,463
Total current assets	8,005,217	8,977,742
Property and equipment, net	1,360,315	552,538
Intangible assets, net	730,835	97,925
Other assets	131,847	46,714
TOTAL ASSETS	10,228,214	9,674,919
CURRENT LIABILITIES
Accounts payable and accrued expenses	2,070,158	2,586,045
Convertible notes payable, current portion	0	50,000
Deferred revenue, current portion	6,457,319	7,564,587
Capital lease liability, current portion	115,761	0
Patent settlement liability, current portion	0	112,500
Total current liabilities	10,638,476	15,439,878
LONG TERM LIABILITIES
Line of credit, long term	2,900,000	2,650,000
Notes payable, related parties, long term, net of current portion, net of discount of $-0- and $117,365, respectively	0	282,635
Notes payable, long term, net of current portion, net of discount of $123,184 and $279,402, respectively	434,316	423,098
Convertible notes payable, related parties, long term, net of current portion	5,770,000	5,770,000
Convertible notes payable, long term, net of current portion	200,000	350,000
Deferred revenue, long term, net of current portion	1,794,237	1,952,366
Capital lease liability, long term, net of current portion	175,089	0
TOTAL LIABILITIES	21,912,118	26,867,977
COMMITMENTS AND CONTINGENCIES (See Note 10)
SHAREHOLDERS' (DEFICIT)
Common stock, 500,000,000 shares authorized, 155,368,647 and 148,542,805 issued and outstanding, respectively, at $0.001 par value	155,370	148,544
Additional paid in capital - preferred	999,750	999,750
Additional paid in capital - common	56,233,085	54,379,454
Accumulated other comprehensive (loss)	(436,505)	(397,237)
Accumulated (deficit)	(68,635,854)	(72,323,819)
TOTAL SHAREHOLDERS' (DEFICIT)	(11,683,904)	(17,193,058)
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT)	10,228,214	9,674,919
Series B Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series C Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series D Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	250	250
Conversion Feature Liability Related Parties [Member]
CURRENT LIABILITIES
Derivative liabilities, current	670,634	1,604,723
Conversion Feature Liability [Member]
CURRENT LIABILITIES
Derivative liabilities, current	35,705	81,224
Warrant Liability Related Parties [Member]
CURRENT LIABILITIES
Derivative liabilities, current	601,781	2,196,570
Warrant Liability [Member]
CURRENT LIABILITIES
Derivative liabilities, current	$ 687,118	$ 1,244,229

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Allowance for doubtful accounts	$ 176,220	$ 149,980
Notes payable discount
Preferred stock, par value (in dollars per share)	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	155,368,647	148,542,805
Common stock, shares outstanding (in shares)	155,368,647	148,542,805
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Series B Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	230,000	230,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, liquidation preference	$ 0	$ 0
Series C Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	747,500	747,500
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, liquidation preference	$ 0	$ 0
Series D Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	250,000	250,000
Preferred stock, shares issued (in shares)	250,000	250,000
Preferred stock, shares outstanding (in shares)	250,000	250,000
Related Party Long Term [Member]
Notes payable discount, noncurrent	$ 0	$ 117,365
Notes Payable, Other Payables [Member]
Notes payable discount	$ 123,184	$ 279,402

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenues	$ 26,129,229	$ 26,067,933
Reimbursable revenues	975,251	911,725
Total revenues	27,104,480	26,979,658
Cost of goods sold	4,284,588	4,394,918
Reimbursable expenses-cost of goods sold	617,509	885,972
Total cost of goods sold	4,902,097	5,280,890
Gross margin	22,202,383	21,698,768
Operating expenses
Salaries, benefits and related taxes	14,094,550	13,200,837
Rent and occupancy expenses	1,254,087	1,125,147
Consulting services	298,097	321,472
Legal and professional fees	477,102	533,221
Travel	856,187	986,092
Telephone and internet	153,540	152,926
Selling, general and administrative	1,676,869	1,356,427
Bad debt expense	41,782	130,346
Intangible asset impairment	79,634	0
Depreciation expense	398,654	336,102
Amortization expense	337,704	22,048
Total operating expenses	19,668,206	18,164,618
Operating income/(loss)	2,534,177	3,534,150
Other income/(expense)
Interest expense, related parties	(935,839)	(947,688)
Interest expense	(406,145)	(419,432)
Interest income	21	593
Change in derivative liabilities	3,111,760	795,779
Transaction gain/(loss)	(125,794)	5,010
Income/(loss) before income taxes	4,178,180	2,968,412
Income tax (expense)	(490,215)	(1,194)
Net income/(loss) attributable to common stockholders	$ 3,687,965	$ 2,967,218
Net income/(loss) per share
Basic (in dollars per share)	$ 0.02	$ 0.02
Diluted (in dollars per share)	$ 0.02	$ 0.02
Weighted average number of shares outstanding
Basic (in shares)	150,832,451	147,865,246
Diluted (in shares)	164,618,868	148,177,984

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income/(Loss) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Net income/(loss) attributable to common stockholders	$ 3,687,965	$ 2,967,218
Other comprehensive income/(loss)
Change in foreign currency translation adjustment	(39,268)	13,268
Other comprehensive income/(loss)	(39,268)	13,268
Comprehensive income/(loss)	$ 3,648,697	$ 2,980,486

Consolidated Statement of Share

Consolidated Statement of Shareholders' (Deficit) - USD ($)	Series D Preferred Stock [Member]Preferred Stock [Member]	Additional Paid In Capital Preferred [Member]	Common Stock [Member]	Additional Paid In Capital Common [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2016	250,000		147,786,917
Balance at Dec. 31, 2016	$ 250	$ 999,750	$ 147,788	$ 53,425,956	$ (75,291,037)	$ (410,505)	$ (21,127,798)
Employee stock option expense				364,271			364,271
Foreign currency translation adjustment						13,268	13,268
Restricted stock issuance/(forfeiture) (in shares)			(16,668)
Restricted stock issuance/(forfeiture)			$ (17)	(2,817)			(2,834)
Cashless issuance of common stock, stock option exercise (in shares)			22,556
Cashless issuance of common stock, stock option exercise			$ 23	(23)			$ 0
Issuance of common stock, stock option exercise (in shares)			250,000				300,000
Issuance of common stock, stock option exercise			$ 250	35,000			$ 35,250
Issuance of common stock, warrant exercise (in shares)			500,000
Issuance of common stock, warrant exercise			$ 500	154,500			155,000
Reclassification of conversion feature liability associated with convertible debt				402,567			402,567
Net income/(loss)	$ 0	0	$ 0	0	2,967,218	0	2,967,218
Balance (in shares) at Dec. 31, 2017	250,000		148,542,805
Balance at Dec. 31, 2017	$ 250	999,750	$ 148,544	54,379,454	(72,323,819)	(397,237)	(17,193,058)
Employee stock option expense				201,562			201,562
Foreign currency translation adjustment						(39,268)	(39,268)
Restricted stock issuance/(forfeiture) (in shares)			925,000
Restricted stock issuance/(forfeiture)			$ 925	93,222			94,147
Cashless issuance of common stock, stock option exercise (in shares)			34,175
Cashless issuance of common stock, stock option exercise			$ 34	(34)			$ 0
Issuance of common stock, stock option exercise (in shares)			200,000				300,000
Issuance of common stock, stock option exercise			$ 200	44,800			$ 45,000
Issuance of common stock, warrant exercise (in shares)			4,000,000
Issuance of common stock, warrant exercise			$ 4,000	1,005,248			1,009,248
Reclassification of conversion feature liability associated with convertible debt				10,500			10,500
Net income/(loss)	$ 0	0	$ 0	0	3,687,965	0	3,687,965
Issuance of common stock, purchase of Acuity software (in shares)			1,666,667
Issuance of common stock, purchase of Acuity software			$ 1,667	498,333			500,000
Balance (in shares) at Dec. 31, 2018	250,000		155,368,647
Balance at Dec. 31, 2018	$ 250	$ 999,750	$ 155,370	$ 56,233,085	$ (68,635,854)	$ (436,505)	$ (11,683,904)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)	$ 3,687,965	$ 2,967,218
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities
Change in derivative liabilities	(3,111,760)	(795,779)
Intangible asset impairment	79,634	0
Interest expense from derivative instruments	273,582	296,182
Employee stock compensation	295,709	568,522
Provision for doubtful accounts	41,782	130,346
Depreciation and amortization	736,358	358,150
Changes in operating assets and liabilities
Accounts receivable	1,275,538	(2,167,733)
Prepaid expenses	(87,081)	(101,216)
Other current assets	6,259	23,592
Other assets	(85,133)	4,607
Accounts payable and accrued expenses	(515,887)	462,972
Patent settlement liability	(112,500)	(858,702)
Deferred revenue	(1,265,397)	(22,277)
Net cash provided by/(used in) operating activities	1,219,069	865,882
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(849,344)	(242,384)
Purchase of Acuity software	(552,403)	0
Net cash (used in) investing activities	(1,401,747)	(242,384)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of notes payable	(345,000)	(915,000)
Repayments of notes payable, related parties	0	(105,000)
Proceeds/(repayments) from revolving line of credit	250,000	(50,000)
Proceeds from exercise of stock options	45,000	35,250
Proceeds from exercise of warrants	600,000	155,000
Principal repayment of capital lease obligation	(67,817)	0
Net cash provided by/(used in) financing activities	482,183	(879,750)
Effect of exchange rate changes on fixed and intangible assets	3,736	(19,797)
Effect of exchange rate changes on cash and cash equivalents	(39,268)	13,268
Net increase/(decrease) in cash and cash equivalents	263,973	(262,781)
Cash and cash equivalents at beginning of year	1,176,551	1,439,332
Cash and cash equivalents at end of year	1,440,524	1,176,551
Supplemental disclosures of cash flow information:
Income taxes	327,319	1,194
Interest	1,144,586	1,051,909
Non-cash transactions:
Notes payable issued in exchange for existing notes payable	0	350,000
Restricted stock issuance/(forfeiture)	94,147	(2,834)
Common stock issued for the purchase of Acuity software	500,000	0
Capital expenditures funded by capital lease borrowing	359,603	0
Reclassification of conversion feature liability associated with convertible debt	10,500	402,567
Reclassification of warrant feature liability associated with warrant exercise	9,248	0
Exercise of warrants as repayment of notes payable, related party	$ 400,000	$ 0

Note 1 - Organization and Natur

Note 1 - Organization and Nature of Operations	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Nature of Operations [Text Block]	NOTE 1: ORGANIZATION AND NATURE OF OPERATIONS OmniComm Systems, Inc. (“OmniComm” or the “Company”) is a healthcare technology company that provides web-based electronic data capture (“EDC”) and eClinical solutions and related value-added services to pharmaceutical and biotechnology companies, contract research organizations (“CROs”), and other clinical trial sponsors principally located in the United States, Europe and East Asia. Our proprietary EDC software applications; TrialMaster ® ® ™ ® ™ Our ability to compete within the EDC and eClinical industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through our EDC software and services. Our research and product development efforts are focused on developing new and complementary software solutions, as well as enhancing our existing software solutions through the addition of increased functionality. During the year ended December 31, 2018 $3,370,233 12.4% December 31, 2017 $2,854,428 10.6%

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company’s accounts include those of all its wholly-owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation. ESTIMATES IN FINANCIAL STATEMENTS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt and warrants issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may RECLASSIFICATIONS Certain reclassifications have been made in the 2017 2018 not FOREIGN CURRENCY TRANSLATION The financial statements of the Company’s foreign subsidiaries are translated in accordance with ASC 830 30, Foreign Currency Matters—Translation of Financial Statements $39,268 December 31, 2018 $13,268 December 31, 2017. REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne, IRTMaster, Promasys eClinical Suite ( “EDC Software”). TrialMaster eClinical Suite For revenue from product sales, the Company recognizes revenue in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 606 606" five 606: not no The Company operates in one four Hosted Application Revenues The Company offers its TrialMaster and TrialOne software products as hosted application solutions delivered through a standard web browser, with customer support and training services. The Company's TrialOne and Promasys solutions are primarily deployed on a technology transfer or off-the-shelf basis. To date, hosted applications revenues have been primarily related to TrialMaster. On April 30, 2019, Revenues resulting from TrialMaster three first second third Fees charged for the trial system design, set-up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC software products with its customers for 3 5 30 45 In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may Professional Services The Company may not Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the years ended December 31, 2018 December 31, 2017, For the year ended Revenue activity December 31, 2018 December 31, 2017 Set-up fees $ 3,792,670 $ 4,981,941 Change orders 1,508,248 1,540,167 Maintenance 5,567,039 5,107,787 Software licenses 11,571,134 10,658,977 Professional services 2,917,556 3,359,554 Hosting 1,747,833 1,331,232 Total $ 27,104,480 $ 26,979,658 COST OF GOODS SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs . CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $176,220 December 31, 2018 $149,980 December 31, 2017. The following table summarizes activity in the Company's allowance for doubtful accounts for the years presented. December 31, 2018 December 31, 2017 Beginning of period $ 149,980 $ 179,813 Bad debt expense 41,782 130,346 Write-offs (15,542 ) (160,179 ) End of period $ 176,220 $ 149,980 CONCENTRATION OF CREDIT RISK Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may December 31, 2018, $861,565 Except as follows, the Company has no December 31, 2018. December 31, 2018, no not One customer accounted for 13% December 31, 2018 $3,528,000. 10% December 31, 2017 $2,691,000. 10% One customer accounted for approximately 20% December 31, 2018. 24% December 31, 2017. Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2018 1 13% 1 20% December 31, 2017 1 10% 1 24% The table below provides revenues from European customers for the years ended December 31, 2018 December 31, 2017. European revenues For the year ended December 31, 2018 December 31, 2017 European revenues % of Total revenues European revenues % of Total revenues $ 4,517,065 17% $ 3,632,537 14% The Company serves all of its hosting customers from third not third may PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3 ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805” 350, Intangibles- Goodwill and Other 350” The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not DEFERRED REVENUE Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may December 31, 2018, $8,251,556 1 6.5 $6,457,319 twelve ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $821,693 December 31, 2018 $701,161 December 31, 2017 RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are included in research and product development and are expensed as incurred. ASC 985.20, Software Industry Costs of Software to Be Sold, Leased or Marketed not 985.20. December 31, 2018 $3,370,233, 12.4% December 31, 2017 $2,854,428, 10.6% third EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. 2016 10,000,000 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 December 31, 2018, 11,025,000 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 2009 7,500,000 2009 Each plan is more fully described in “Note 13, ASC 718, Compensation – Stock Compensation ASC 718 EARNINGS/(LOSS) PER SHARE The Company accounts for Earnings/(loss) Per Share using ASC 260 INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, Income Taxes. 740 Valuation allowances are established, when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. On December 22, 2017, 21 January 1, 2018. 740, Income Taxes December 31, 2017, 2l 14. IMPACT OF NEW ACCOUNTING STANDARDS In February 2016, No. 2016 02, “Leases (Topic 842 )” 2016 02” 12 December 15, 2018. In March 2016, April 2016, December 2016, 2016 08, Revenue from Contracts with Customers - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) 2016 08” 2016 10, Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing 2016 10” 2016 20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers" 2016 20” 2014 09. May 2016, 2016 12, Revenue from Contracts with Customers - Narrow Scope Improvements and Practical Expedients 2014 09, December 15, 2016, not In July 2017, 2017 11 Earnings per Share (Topic 260 ), Distinguishing Liabilities from Equity (Topic 480 ), Derivatives and Hedging (Topic 815 ) 2017 11” 480 not 2017 11 December 15, 2018, 2017 11. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note 3 - Earnings (Loss) Per Sh

Note 3 - Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 3: EARNINGS/(LOSS) PER SHARE Basic income/(loss) per share was calculated using the weighted average number of shares outstanding of 150,832,451 December 31, 2018 147,865,246 December 31, 2017. Antidilutive shares aggregating 13,390,677 December 31, 2018 43,343,224 December 31, 2017 December 31, 2018 December 31, 2017. Anti-dilutive security December 31, 2018 December 31, 2017 Employee stock options 725,000 4,225,000 Warrants 12,550,000 27,020,000 Convertible notes -0- 11,980,000 Shares issuable for accrued interest 115,677 118,224 Total 13,390,677 43,343,224 The employee stock options are exercisable at prices ranging from $0.17 $0.34 $0.25 $0.60 $0.25 $0.50 Provided below is the reconciliation between numerators and denominators of the basic and diluted income/(loss) per shares. For the year ended December 31, 2018 December 31, 2017 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 3,687,965 150,832,451 $ 0.02 $ 2,967,218 147,865,246 $ 0.02 Effect of dilutive securities (280,117 ) 13,786,417 (0.02 ) 4,766 312,738 -0- Diluted EPS $ 3,407,848 164,618,868 $ 0.02 $ 2,971,984 148,177,984 $ 0.02

Note 4 - Property and Equipment

Note 4 - Property and Equipment, Net	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4: PROPERTY AND EQUIPMENT, NET Property and equipment consists of the following: December 31, 2018 December 31, 2017 Description Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 3,067,069 $ 2,202,166 $ 864,903 $ 2,322,833 $ 1,949,982 $ 372,851 5 Leasehold improvements 136,648 106,362 30,286 118,380 98,901 19,479 5 Computer software 2,426,339 1,991,842 434,497 2,010,999 1,886,342 124,657 3 Office furniture 169,120 138,491 30,629 162,799 127,248 35,551 5 Total $ 5,799,176 $ 4,438,861 $ 1,360,315 $ 4,615,011 $ 4,062,473 $ 552,538 Depreciation expense was $398,654 December 31, 2018 $336,102 December 31, 2017.

Note 5 - Intangible Assets, Net

Note 5 - Intangible Assets, Net	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	NOTE 5: INTANGIBLE ASSETS, NET Intangible assets consist of the following: December 31, 2018 December 31, 2017 Asset Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer lists $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer lists 113,220 113,220 -0- 118,780 32,994 85,786 15 Promasys B.V. software code 72,837 72,837 -0- 72,837 60,698 12,139 5 Promasys B.V. URLs/website 57,182 57,182 -0- 59,990 59,990 -0- 3 Acuity software code 1,052,403 321,568 730,835 -0- -0- -0- 3 Total $ 2,688,343 $ 1,957,508 $ 730,835 $ 1,644,308 $ 1,546,383 $ 97,925 During the second 2018 $79,634 Amortization expense was $337,704 December 31, 2018 $22,048 December 31, 2017. Annual amortization expense for the Company’s intangible assets is as follows: Year Amortization 2019 $ 350,801 2020 350,801 2021 29,233 Total $ 730,835

Note 6 - Accounts Payable and A

Note 6 - Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 6: ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following: Account December 31, 2018 December 31, 2017 Accounts payable $ 895,145 $ 1,303,073 Accrued payroll and related costs 851,530 925,890 Other accrued expenses 250,570 184,131 Accrued interest 72,913 172,951 Total accounts payable and accrued expenses $ 2,070,158 $ 2,586,045

Note 7 - Line of Credit, Notes

Note 7 - Line of Credit, Notes Payable and Liquidity	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 7: LINE OF CREDIT, NOTES PAYABLE AND LIQUIDITY On March 18, 2013, $2,000,000 2.0% $9,500 December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. April 7, 2017 April 7, 2020 December 31, 2018, $2,900,000 4.5%. Our primary sources of working capital are funds from operations and borrowings under our Line of Credit. In the event that the Line of Credit is called for any reason, Mr. Wit has pledged to replace the borrowing capacity under the Line of Credit with a promissory note that utilizes the same maturity date and interest rate as the Line of Credit. To satisfy our capital requirements, we may no not may may At December 31, 2018, $557,500 Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2018 Current term Current term 6/30/2016 4/1/2020 10% $ 420,000 $ -0- $ 420,000 $ -0- $ -0- 6/30/2016 4/1/2020 12% 137,500 -0- 137,500 -0- -0- Discount on notes payable -0- (123,184 ) -0- -0- Total $ 557,500 $ -0- $ 434,316 $ -0- $ -0- At December 31, 2017, $1,102,500 Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2017 Current term Current term 2/29/2016 4/1/2019 12% $ 400,000 $ -0- $ -0- $ -0- $ 400,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 282,500 -0- 282,500 -0- -0- Discount on notes payable -0- (279,402 ) -0- (117,365 ) Total $ 1,102,500 $ -0- $ 423,098 $ -0- $ 282,635 On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. December 5, 2016 1,000,000 December 27, 2018, $400,000 $400,000 1,600,000 2,000,000 $0.25 This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $325,689 $124,311. 37 On June 30, 2016, $372,500 1,490,000 $0.25 April 1, 2020 two 12% April 1, 2020. August 31, 2017 $90,000 December 31, 2018, $145,000 one This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $246,921 $125,579. 45 On June 30, 2016, $420,000 1,680,000 $0.25 April 1, 2020 two 10% April 1, 2020. This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $278,408 $141,592. 45

Note 8 - Convertible Notes Paya

Note 8 - Convertible Notes Payable	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Convertible Debt Disclosure [Text Block]	NOTE 8: CONVERTIBLE NOTES PAYABLE The following table summarizes the convertible debt outstanding as of December 31, 2018. Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2018 Related Non related Related Non related 8/29/2008 4/1/2020 10% $ 1,770,000 $ -0- $ -0- $ 1,770,000 $ -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 5,970,000 $ -0- $ 0 $ 5,770,000 $ 200,000 The following table summarizes the convertible debt outstanding as of December 31, 2017. Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2017 Related Non related Related Non related 8/1/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2019 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 6,170,000 $ -0- $ 50,000 $ 5,770,000 $ 350,000 10% During 1999 10% $862,500 $119,625 $742,875. 10% June 30, 2004, $1.25 September 30, 2018, $50,000 $96,949. December 31, 2018, $862,500 1,495,179 0 Secured Convertible Debentures On September 30, 2009 $1,400,000 12% 5,600,000 $0.25 four four $1,400,000. 12% March 30, 2011. $0.25 On March 30, 2011 $200,000 $1,200,000 April 1, 2013, $1,100,000 On February 22, 2013 two $1,200,000 January 1, 2016, $1,100,000 January 1, 2016. On January 31, 2015 $1,100,000 April 1, 2017. April 1, 2017. November 19, 2015 $475,000 1,900,000 November 19, 2015 1,900,000 $475,000 $475,000 1,900,000 November 23, 2015 $625,000 two On April 1, 2015 $100,000 April 1, 2018. April 1, 2018. June 30, 2017 $100,000 On June 30, 2016 two $625,000 April 1, 2020. April 1, 2020. August 2017 $625,000 Convertible Debentures August 2008 On August 29, 2008 $2,270,000 4,540,000 four one 10% August 29, 2010. $0.50 On September 30, 2009 two $1,920,000 August 29, 2013 On February 22, 2013 $1,770,000 January 1, 2016. January 1, 2016. On February 22, 2013 $150,000 January 1, 2015. January 1, 2015. On April 21, 2014 $150,000 April 1, 2016. April 1, 2016. July 31, 2014 $150,000 On January 31, 2015 $1,770,000 April 1, 2017. April 1, 2017. On June 30, 2015 $150,000 April 1, 2017. April 1, 2017. On June 30, 2016 $1,770,000 April 1, 2020. April 1, 2020. On June 30, 2016 $150,000 April 1, 2018. April 1, 2018. On June 30, 2017 $150,000 April 1, 2019. April 1, 2019. On June 30, 2018, $150,000 December 2008 On December 16, 2008 $5,075,000 10,150,000 eleven four 12% December 16, 2010. $0.50 On September 30, 2009 eight $4,980,000 December 16, 2013 On February 22, 2013 $4,505,000 $4,475,000 $25,000 $5,000 January 1, 2016. January 1, 2016. May 1, 2015 $5,000 On February 27, 2013 $15,000 January 1, 2016. January 1, 2016. On March 6, 2013 $200,000 January 1, 2014. January 1, 2014. On March 12, 2013 $100,000 January 1, 2015. January 1, 2015. In December 2013 two $360,000 $160,000 January 1, 2016. January 1, 2016. July 31, 2014 $160,000 On April 28, 2014 $100,000 April 1, 2016. April 1, 2016. On January 31, 2015 $4,475,000 April 1, 2017. April 1, 2017. November 19, 2015 $420,000 1,680,000 1,680,000 On April 27, 2015 $200,000 April 1, 2018. April 1, 2018. On April 30, 2015 $25,000 April 1, 2018. April 1, 2018. $25,000 December 14, 2016. On May 1, 2015 $160,000 April 1, 2017. April 1, 2017. On May 7, 2015 $15,000 April 1, 2018. April 1, 2018. $15,000 December 14, 2016. On June 30, 2015 $100,000 April 1, 2017. April 1, 2017. On June 30, 2016 $4,055,000 April 1, 2020. April 1, 2020. August 31, 2017 $55,000 On June 30, 2016 $160,000 April 1, 2018. April 1, 2018. $160,000 December 14, 2016. On June 30, 2016 $100,000 April 1, 2020. April 1, 2020. $100,000 August 31, 2017. On June 30, 2017 $200,000 April 1, 2021. April 1, 2021. The payments required at maturity under the Company’s outstanding convertible debt at December 31, 2018 Year Amount 2019 $ -0- 2020 5,770,000 2021 200,000 Total $ 5,970,000

Note 9 - Fair Value Measurement

Note 9 - Fair Value Measurement	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 9: FAIR VALUE MEASUREMENT The Company measures the fair value of its assets and liabilities under the guidance of ASC 820, Fair Value Measurements and Disclosures 820 not ASC 820 820 ● Level 1: ● Level 2: ● Level 3: no The valuation techniques that may ● Market approach - Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities ● Income approach - Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method ● Cost approach - Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost) The Company also adopted the provisions of ASC 825, Financial Instruments ASC 825 may not not December 31, 2018 December 31, 2017. The Company’s financial assets or liabilities subject to ASC 820 December 31, 2018 2008 2009, 2011 2016 2013. not not 815 Disclosures about Derivative Instruments and Hedging Activities 8 Following is a description of the valuation methodologies used to determine the fair value of the Company’s financial assets including the general classification of such instruments pursuant to the valuation hierarchy. A summary as of December 31, 2018 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Derivatives: (1) (2) December 31, 2018 (Level 1) (Level 2) (Level 3) Conversion feature liability $ 706,339 $ -0- $ -0- $ 706,339 Warrant liability 1,288,899 -0- -0- 1,288,899 Total of derivative liabilities $ 1,995,238 $ -0- $ -0- $ 1,995,238 ( 1 December 31, 2018. ( 2 Significant valuation assumptions for derivative instruments at December 31, 2018 Risk free interest rate 2.70% to 2.70% Dividend yield 0.00% Expected volatility 92.2% to 97.0% Expected life (range in years) Conversion feature liability 1.25 to 2.25 Warrant liability 0.00 to 2.25 A summary as of December 31, 2018 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Acquired assets (1) December 31, 2017 December 31, 2018 (Level 1) (Level 2) (Level 3) Promasys B.V. customer list (2) (3) $ 85,786 $ -0- $ -0- $ -0- $ 136,253 Promasys B.V. software code (2) 12,139 -0- -0- -0- 72,943 Acuity software code (4) -0- 730,835 -0- -0- 1,052,403 Total $ 97,925 $ 730,835 $ -0- $ -0- $ 1,261,599 ( 1 ( 2 not ( 3 second 2018 $79,634 ( 4 not A summary as of December 31, 2017 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Derivatives: (1) (2) December 31, 2017 (Level 1) (Level 2) (Level 3) Conversion feature liability $ 1,685,947 $ -0- $ -0- $ 1,685,947 Warrant liability 3,440,799 -0- -0- 3,440,799 Total of derivative liabilities $ 5,126,746 $ -0- $ -0- $ 5,126,746 ( 1 December 31, 2017. ( 2 Significant valuation assumptions for derivative instruments at December 31, 2017 Risk free interest rate 1.56% to 1.81% Dividend yield 0.00% Expected volatility 87.0% to 118.4% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25 A summary as of December 31, 2017 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Acquired assets (1) December 30, 2016 December 31, 2017 (Level 1) (Level 2) (Level 3) Promasys B.V. customer list (2) $ 82,173 $ 85,786 $ -0- $ -0- $ 136,253 Promasys B.V. software code (2) 26,707 12,139 -0- -0- 72,943 Total $ 108,880 $ 97,925 $ -0- $ -0- $ 209,196 ( 1 ( 2 not Other identifiable intangible assets, which are subject to amortization, are being amortized using the straight-line method over their estimated useful lives ranging from 3 15 may not Other income/(expense) For the year ended December 31, 2018 December 31, 2017 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date $ 3,111,760 $ 795,779 Total unrealized and realized gains/(losses) included in earnings $ 3,111,760 $ 795,779 The tables below set forth a summary of changes in fair value of the Company’s Level 3 December 31, 2018 December 31, 2017. 3 December 31, 2018 December 31, 2017. Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, beginning Net realized Net unrealized and associated with end Derivatives: of year gains/(losses) gains/(losses) settlements convertible debt of year Conversion feature liability $ (1,685,947 ) $ -0- $ 969,108 $ -0- $ 10,500 $ (706,339 ) Warrant liability (3,440,799 ) -0- 2,142,652 9,248 -0- (1,288,899 ) Total of derivative liabilities $ (5,126,746 ) $ -0- $ 3,111,760 $ 9,248 $ 10,500 $ (1,995,238 ) Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, beginning Net realized Net unrealized and associated with end Derivatives: of year gains/(losses) gains/(losses) settlements convertible debt of year Conversion feature liability $ (2,325,730 ) $ 48,375 $ 188,841 $ -0- $ 402,567 $ (1,685,947 ) Warrant liability (3,999,362 ) -0- 558,563 -0- -0- (3,440,799 ) Total of derivative liabilities $ (6,325,092 ) $ 48,375 $ 747,404 $ -0- $ 402,567 $ (5,126,746 )

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 10: COMMITMENTS AND CONTINGENCIES The Company currently leases office space under operating leases for its office locations and has several operating leases related to server and network co-location and disaster recovery for its operations. The minimum future lease payments required under the Company’s operating leases at December 31, 2018 Year Payments 2019 $ 655,901 2020 414,973 2021 340,029 2022 340,270 Thereafter 76,243 Total $ 1,827,416 In addition to annual base rental payments, the Company pays for the operating expenses associated with its leased office space and is responsible for any escalation in operating expenses as determined in the leases. Rent expense was $1,254,087 December 31, 2018 $1,125,147 December 31, 2017. The Company’s corporate office lease expires in February 2023. March 2021. September 2020. July 2019. October 2019. May 2023. The Company currently leases computer hardware for its operations under leases classified as capital leases. The leased equipment is amortized on a straight line basis over five December 31, 2018 Year Payments 2019 $ 131,067 2020 131,067 2021 52,398 Total minimum capital lease payments 314,532 Less: Amount representing interest (23,682 ) Present value of minimum capital lease payments $ 290,850 LEGAL PROCEEDINGS From time to time the Company may December 31, 2018, no PATENT LITIGATION SETTLEMENT Effective April 2, 2009, June 18, 2008 No. 6,496,827 B2 may may January 1, 2008 December 31, 2017 two 2% thirty 30 thirty 30 may 1,000,000 $.01 $300,000. second April 2, 2011, December 31, 2017. December 31, 2017 50% 500,000 50% 500,000 $145,000. December 31, 2017 no On June 23, 2009, may $300,000. The Company recorded a credit to earnings of $- 0 December 31, 2018 $108,702 December 31, 2017, 1 December 31, 2018 December 31, 2017 2 EMPLOYMENT AGREEMENTS The Company has employment agreements in place with the following members of our executive management team: Cornelis F. Wit, Executive Chairman Randall G. Smith, Executive Vice Chairman Stephen E. Johnson, Chief Executive Officer and President Thomas E. Vickers, Chief Financial Officer The employment agreements provide, among other things, for participation in employee benefits available to employees and executives. Each of the agreements will renew for successive one ninety may 30 may 12

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 11: RELATED PARTY TRANSACTIONS As of December 31, 2018, $5,770,000 ● In June 2008, $510,000 August 29, 2008, $510,000 $1,260,000 3,540,000 10% August 29, 2010. $0.50 September 30, 2009, $1,770,000 August 29, 2013 February 22, 2013, $1,770,000 January 1, 2016. January 1, 2016. January 31, 2015 $1,770,000 April 1, 2017. April 1, 2017. June 30, 2016 $1,770,000 April 1, 2020. April 1, 2020. ● In February 2008, $150,000 September 2008 December 2008, $4,200,000 December 16, 2008, $4,350,000 8,700,000 12% December 16, 2010. $0.50 September 30, 2009, $4,350,000 December 16, 2013 October 16, 2012, $125,000 December 2008 250,000 February 22, 2013, $4,475,000 January 1, 2016. January 1, 2016. January 31, 2015 $4,475,000 April 1, 2017. April 1, 2017. November 19, 2015 $420,000 1,680,000 1,680,000 June 30, 2016 $4,055,000 April 1, 2020. April 1, 2020. August 31, 2017, $55,000 ● On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. August 31, 2017, $50,000 December 27, 2018, $400,000 $400,000 1,600,000 2,000,000 $0.25 On March 18, 2013, $2,000,000 December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. April 7, 2017 2.0% $9,500 April 7, 2020 December 31, 2018, $2,900,000 4.5%. The Company incurred interest expense payable to related parties of $935,839 December 31, 2018 $947,688 December 31, 2017.

Note 12 - Stockholders' (Defici

Note 12 - Stockholders' (Deficit)	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 12: STOCKHOLDERS’ (DEFICIT) Our authorized capital stock consists of 500,000,000 $.001 10,000,000 $.001 5,000,000 5% 230,000 747,500 250,000 As of December 31, 2018 ● 155,368,647 ● 22,020,000 ● 2,570,000 ● 250,000 ● $5,970,000 11,940,000 Common Stock Holders of common stock are entitled to one not Holders of common stock have no no may On March 24, 2017 16,668 On June 26, 2017 22,556 On August 2, 2017 2012. 100,000 On September 29, 2017 50,000 On September 29, 2017 2012. 100,000 On December 31, 2017 50% 500,000 On January 30, 2018, 1,666,667 January 30, 2018 On May 16, 2018 100,000 On June 15, 2018 100,000 On September 6, 2018 225,000 900,000 On September 6, 2018 200,000 five 1,000,000 On October 28, 2018 October 2013. 34,175 On December 27, 2018 2,000,000 2,000,000 $0.25 On December 27, 2018 1,000,000 1,000,000 $0.25 On December 31, 2018 1,000,000 1,000,000 $0.25 Effective December 31, 2018 150,000 225,000 September 6, 2018 600,000 not Effective December 31, 2018 75,000 200,000 five September 6, 2018 375,000 not Preferred stock Our Board of Directors, without further stockholder approval, may one may ● dividend and liquidation preferences, ● voting rights, ● conversion privileges, and ● redemption terms. Our Board of Directors may The following table presents the cumulative arrearage of undeclared dividends by class of preferred stock as of December 31, 2018 December 31, 2017 Cumulative arrearage Cumulative arrearage per share December 31, December 31, Series of preferred stock 2018 2017 2018 2017 Series B $ 609,887 $ 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 2,081,980 Series A Preferred Stock In 1999, 5,000,000 5% 0 The designations, rights and preferences of the Series A Preferred include: ● the shares are not ● each share of Series A Preferred Stock is convertible into shares of our common stock at any time at the option of the holder at a conversion price of $1.11 not one $3.00 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share. The Series A Preferred Stockholders have waived their rights to an anti-dilution adjustment reducing their conversion price as a result of the issuance of the Series B Preferred Stock and Series C Preferred Stock, ● the shares of Series A Preferred Stock pay a cumulative dividend at a rate of 5% $1.00 ● in the event of our liquidation or winding up, each share of Series A Preferred Stock has a liquidation preference equal to $1.00 ● the holders of the Series A Preferred Stock are entitled to vote together with the holders of our common stock, on the basis of one In addition, the holders of the Series A Preferred Stock were granted certain demand and piggy-back registration rights for the shares of our common stock issuable upon the conversion of the Series A Preferred Stock. Prior to 2015 235,000 5% In December 2015 34 4 December 31, 2015 four 5% 487,500 1,950,000 first 4 2016, 3,637,724 14,615,696 Series B Preferred Stock In August 2001, 200,000 February 7, 2002 230,000 0 The designations, rights and preferences of the Series B Preferred Stock include: ● the stated value of each share is $10.00 ● the shares are not ● each share of Series B Preferred Stock is convertible into shares of our common stock at the option of the holder at any time commencing January 31, 2002 $0.25 $0.25 $25 $0.75 may $0.50 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share or market value of the common stock, ● the shares of Series B Preferred Stock pay a cumulative dividend at a rate of 8% $10.00 ● each share of Series B Preferred Stock will rank senior to our Series A Preferred and pari passu with our Series C Preferred Stock, ● in the event of our liquidation or winding up, each share of Series B Preferred Stock has a liquidation preference equal to $10.00 ● the holders of the Series B Preferred Stock are entitled to vote, together with the holders of our common stock, on the basis of one There were cumulative arrearages of $609,887 $609,887, $3.05 $3.05 December 31, 2018 December 31, 2017, The Company has 200,000 In addition, the holders of the Series B Preferred Stock were granted certain mandatory and piggy-back registration rights for the shares of our common stock issuable upon the conversion of the Series B Preferred Stock and were entitled to vote one Series C Preferred Stock In March 2002, 747,500 0 The designations, rights and preferences of the Series C Preferred Stock include: ● the stated value of each share is $10.00 ● the shares are not ● each share of Series C Preferred Stock is convertible at any time, at the option of the holder, into a number of shares of common stock determined by dividing the stated value per share of the Series C Preferred Stock by $0.25, $25,000,000 2.5 two 20 not 30 10 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share or market value of the common stock, ● the shares of Series C Preferred Stock pay a cumulative dividend at a rate of 8% $10.00 ● each share of Series C Preferred Stock will rank pari passu with our Series B Preferred Stock and senior to our Series A Preferred Stock, ● in the event of our liquidation or winding up, each share of Series C Preferred Stock has a liquidation preference equal to $10.00 ● the holders of the Series C Preferred Stock are entitled to vote, together with the holders of our common stock, on the basis of one There were cumulative arrearages of $1,472,093 $1,472,093, $4.37 $4.37 December 31, 2018 December 31, 2017, The Company has 337,150 In addition, the holders of the Series C Preferred Stock were granted certain mandatory and piggy-back registration rights covering the shares of our common stock issuable upon the conversion of the Series C Preferred Stock and were entitled to vote two Series D Preferred Stock In November 2010, 250,000 250,000 The designations, rights and preferences of the Series D Preferred Stock include: ● the stated value of the Series D Preferred is $0.001 ● the Series D Preferred has no ● the shares of Series D Preferred are not ● except as provided in Series D Preferred Designation, in the case of the death or disability of Series D Preferred holder, the Series D Preferred is not ● each share of Series D Preferred entitles the holder to four hundred 400 ● in the event of the liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, the holders of shares of the Series D Preferred then outstanding are entitled to receive before holders of shares of common stock receive any amounts, out of the remaining assets of the Corporation available for distribution to its stockholders, an amount equal to $0.001 ● so long as any shares of Series D Preferred are outstanding, the Company cannot without first ● the holders of the Series D Preferred are not ● the Company has a thirty 30 first ● the holders of Series D Preferred cannot, directly or indirectly, transfer any shares of Series D Preferred. Any such purported transfer shall be of no not Warrants Issued for Services and in Capital Transactions The following tables summarize all warrants issued as part of debt transactions for the years ended December 31, 2018 December 31, 2017, December 31, 2018 December 31, 2018 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 – $0.60 22,020,000 1.06 $ 0.45 22,020,000 $ 0.45 December 31, 2017 December 31, 2017 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 – $0.60 27,020,000 1.84 $ 0.42 27,020,000 $ 0.42 Warrants Balance at December 31, 2016 27,860,000 Issued -0- Exercised -0- Expired/forfeited (840,000 ) Balance at December 31, 2017 27,020,000 Issued -0- Exercised (4,000,000 ) Expired/forfeited (1,000,000 ) Balance at December 31, 2018 22,020,000 Warrants exercisable at December 31, 2018 22,020,000 Weighted average fair value of warrants granted during 2018 n/a Other Comprehensive Income/(Loss) Due to the availability of net operating losses and related deferred tax valuations, there is no Foreign currency translation Accumulated other comprehensive income/(loss) Balance at December 31, 2016 $ (410,505 ) $ (410,505 ) 2017 Activity 13,268 13,268 Balance at December 31, 2017 (397,237 ) (397,237 ) 2018 Activity (39,268 ) (39,268 ) Balance at December 31, 2018 $ (436,505 ) $ (436,505 )

Note 13 - Employee Equity Incen

Note 13 - Employee Equity Incentive Plans	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 13: EMPLOYEE EQUITY INCENTIVE PLANS Stock Option Plans Description of 2016 In 2016, 2016 “2016 2016 2016 10,000,000 2016 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 2016 June 29, 2026. December 31, 2018, 11,025,000 2016 The maximum term for any option grant under the 2016 ten 2016 five 2016 two may may first 50% one second second 2016 three not 2016 On September 6, 2018, $0.33 225,000 75,000 2018 $30 2018 $6 75,000 2018 $32 2018 $7 75,000 1/3 second third 2018 June 7, 2018. December 31, 2018 not 150,000 225,000 On September 6, 2018, $0.33 200,000 2019 75,000 2018 $30 2018 $6 December 31, 2018 not 75,000 200,000 As of December 31, 2018, 2,395,000 100,000 925,000 2016 December 31, 2018, 7,605,000 2016 Description of 2009 In 2009, 2009 “2009 2009 2009 7,500,000 The maximum term for any option grant under the 2009 ten 2009 five 2009 two first 50% one second second 2009 three not 2009 2009 2016 No 2009 As of December 31, 2018, 175,000 3,876,662 2009 December 31, 2018, 0 2009 The following table summarizes the stock option activity for the Company’s equity incentive plans: Number of options Weighted average exercise price Weighted average remaining contractual term Aggregate intrinsic value Outstanding at December 31, 2016 1,225,000 $ 0.17 2.62 $ 83,425 Granted 4,650,000 0.26 Exercised (300,000 ) 0.13 Forfeited/cancelled/expired (300,000 ) 0.14 Outstanding at December 31, 2017 5,275,000 0.26 4.09 $ 130,475 Granted 570,000 0.28 Exercised (300,000 ) 0.21 Forfeited/cancelled/expired (2,975,000 ) 0.25 Outstanding at December 31, 2018 2,570,000 $ 0.28 3.47 $ 16,675 Vested and exercisable at December 31, 2018 887,500 $ 0.25 2.92 $ 14,425 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company’s closing stock price at fiscal year-end and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2018. The total number of shares vested and the fair value of shares vested for the years ended December 31, 2018 December 31, 2017, Fair value of options vesting Number of options vested Fair value of options vested December 31, 2018 812,500 $ 179,978 December 31, 2017 62,500 $ 12,742 Cash received from stock option exercises for the year ended December 31, 2018 $45,000 $35,250 December 31, 2017. no December 31, 2018 December 31, 2017. The following table summarizes information concerning options outstanding at December 31, 2018: Awards breakdown by price range at December 31, 2018 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 150,000 0.93 $ 0.17 150,000 0.93 $ 0.17 0.21 to 0.30 1,695,000 3.54 0.26 550,000 3.15 0.25 0.31 to 0.50 725,000 3.82 0.34 187,500 3.82 0.34 0.00 to 0.50 2,570,000 3.47 $ 0.28 887,500 2.92 $ 0.25 The following table summarizes information concerning options outstanding at December 31, 2017: Awards breakdown by price range at December 31, 2017 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 300,000 1.93 $ 0.18 250,000 1.48 $ 0.17 0.21 to 0.30 4,250,000 4.12 0.25 150,000 1.30 0.22 0.31 to 0.50 725,000 4.82 0.34 -0- 0.00 0.00 0.00 to 0.50 5,275,000 4.09 $ 0.26 400,000 1.42 $ 0.19 The weighted average fair value (per share) of options granted during the year ended December 31, 2018 $0.23 $0.21 December 31, 2017 Basis for Fair Value Estimate of Share-Based Payments Based on analysis of its historical volatility, the Company expects that the future volatility of its share price is likely to be similar to the historical volatility the Company experienced since the Company’s commercialization activities were initiated during the second 2000. 2018 2017. may The Company utilizes the historical data available regarding employee and director exercise activity to calculate an expected life of the options. The table below presents the weighted average expected life in years of options granted under the Plan as described above. The risk-free rate of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant, which corresponds with the expected term of the option granted. The fair value of share-based payments was estimated using the Black Scholes option pricing model with the following assumptions for grants made during the periods indicated. Stock option assumptions for the period ended Stock option assumptions December 31, 2018 December 31, 2017 Risk-free interest rate 2.91% 1.81% Expected dividend yield 0.0% 0.0% Expected volatility 111.0% 127.1% Expected life of options (in years) 5 5 The following table summarizes weighted average grant date fair value for the Company incentive stock plans: Weighted average grant date fair value for the year ended December 31, 2018 2017 Stock options granted during the period $ 0.23 $ 0.21 Stock options vested during the period $ 0.22 $ 0.20 Stock options forfeited during the period $ 0.19 $ 0.13 A summary of the status of the Company’s non-vested shares underlying stock options as of December 31, 2018, December 31, 2018 Shares underlying stock options Weighted average grant date fair value Nonvested shares at January 1, 2018 4,875,000 $ 0.21 Nonvested shares at December 31, 2018 1,682,500 $ 0.24 As of December 31, 2018, $267,766 1.88

Note 14 - Income Taxes

Note 14 - Income Taxes	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 14: INCOME TAXES A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate to the income before provision for income taxes is as follows: December 31, 2018 December 31, 2017 Federal statutory rate applied to income/(loss) before income taxes $ 1,058,960 $ 1,117,014 Increase/(decrease) in income taxes results from: Current tax expense/(benefit) 490,215 1,194 Nondeductible expenses (582,309 ) (44,845 ) Change in deferred assets 18,354 (35,423 ) Change in valuation allowance (495,005 ) (1,036,746 ) Income tax expense/(benefit) $ 490,215 $ 1,194 The components of income tax expense/(benefit) for the year ended: December 31, 2018 December 31, 2017 Current tax expense/(benefit): $ 490,215 $ 1,194 Deferred tax expense/(benefit): Bad debt allowance (6,651 ) 11,226 Operating loss carryforward 483,302 1,060,942 Amortization of intangibles 18,354 5,482 Patent litigation settlement -0- (40,904 ) 985,220 1,037,940 Valuation allowance (495,005 ) (1,036,746 ) Total tax expense/(benefit) $ 490,215 $ 1,194 Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows: December 31, 2018 December 31, 2017 Amortization of intangibles $ 253,466 $ 261,771 Bad debt allowance 68,133 55,436 Patent litigation liability accrual 359,377 169,709 Impact of the Tax Cuts and Jobs Act -0- (1,699,440 ) Operating loss carryforwards 15,585,125 17,973,631 Gross deferred tax assets 16,266,101 16,761,107 Valuation allowance (16,266,101 ) (16,761,107 ) Net deferred tax liability/(asset) $ -0- $ -0- The Company has net operating loss carry forwards (NOL) for income tax purposes of approximately $30,636,792. 2038 1998. December 31, 2018. December 31, 2018 $495,005. three On December 22, 2017, 2018 21 January 1, 2018. $1,699,440, $1,699,440 December 31, 2018.

Note 15 - Subsequent Events

Note 15 - Subsequent Events	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 15: SUBSEQUENT EVENTS Subsequent to December 31, 2018 $1,400,000 Subsequent to December 31, 2018 2018 not Subsequent to December 31, 2018 1,800,000 $0.25 1,800,000 Subsequent to December 31, 2018 1,000,000 $0.25 209,694 Subsequent to December 31, 2018 225,000 three F- 36

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company’s accounts include those of all its wholly-owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	ESTIMATES IN FINANCIAL STATEMENTS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt and warrants issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may
Reclassification, Policy [Policy Text Block]	RECLASSIFICATIONS Certain reclassifications have been made in the 2017 2018 not
Foreign Currency Transactions and Translations Policy [Policy Text Block]	FOREIGN CURRENCY TRANSLATION The financial statements of the Company’s foreign subsidiaries are translated in accordance with ASC 830 30, Foreign Currency Matters—Translation of Financial Statements $39,268 December 31, 2018 $13,268 December 31, 2017.
Revenue Recognition, Policy [Policy Text Block]	REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne, IRTMaster, Promasys eClinical Suite ( “EDC Software”). TrialMaster eClinical Suite For revenue from product sales, the Company recognizes revenue in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 606 606" five 606: not no The Company operates in one four Hosted Application Revenues The Company offers its TrialMaster and TrialOne software products as hosted application solutions delivered through a standard web browser, with customer support and training services. The Company's TrialOne and Promasys solutions are primarily deployed on a technology transfer or off-the-shelf basis. To date, hosted applications revenues have been primarily related to TrialMaster. On April 30, 2019, Revenues resulting from TrialMaster three first second third Fees charged for the trial system design, set-up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC software products with its customers for 3 5 30 45 In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may Professional Services The Company may not Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the years ended December 31, 2018 December 31, 2017, For the year ended Revenue activity December 31, 2018 December 31, 2017 Set-up fees $ 3,792,670 $ 4,981,941 Change orders 1,508,248 1,540,167 Maintenance 5,567,039 5,107,787 Software licenses 11,571,134 10,658,977 Professional services 2,917,556 3,359,554 Hosting 1,747,833 1,331,232 Total $ 27,104,480 $ 26,979,658
Cost of Sales, Policy [Policy Text Block]	COST OF GOODS SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs .
Cash and Cash Equivalents, Policy [Policy Text Block]	CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90
Receivables, Policy [Policy Text Block]	ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $176,220 December 31, 2018 $149,980 December 31, 2017. The following table summarizes activity in the Company's allowance for doubtful accounts for the years presented. December 31, 2018 December 31, 2017 Beginning of period $ 149,980 $ 179,813 Bad debt expense 41,782 130,346 Write-offs (15,542 ) (160,179 ) End of period $ 176,220 $ 149,980
Concentration Risk, Credit Risk, Policy [Policy Text Block]	CONCENTRATION OF CREDIT RISK Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may December 31, 2018, $861,565 Except as follows, the Company has no December 31, 2018. December 31, 2018, no not One customer accounted for 13% December 31, 2018 $3,528,000. 10% December 31, 2017 $2,691,000. 10% One customer accounted for approximately 20% December 31, 2018. 24% December 31, 2017. Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2018 1 13% 1 20% December 31, 2017 1 10% 1 24% The table below provides revenues from European customers for the years ended December 31, 2018 December 31, 2017. European revenues For the year ended December 31, 2018 December 31, 2017 European revenues % of Total revenues European revenues % of Total revenues $ 4,517,065 17% $ 3,632,537 14% The Company serves all of its hosting customers from third not third may
Property, Plant and Equipment, Policy [Policy Text Block]	PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805” 350, Intangibles- Goodwill and Other 350” The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not
Deferred Revenue, Policy [Policy Text Block]	DEFERRED REVENUE Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may December 31, 2018, $8,251,556 1 6.5 $6,457,319 twelve
Advertising Costs, Policy [Policy Text Block]	ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $821,693 December 31, 2018 $701,161 December 31, 2017
Research, Development, and Computer Software, Policy [Policy Text Block]	RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are included in research and product development and are expensed as incurred. ASC 985.20, Software Industry Costs of Software to Be Sold, Leased or Marketed not 985.20. December 31, 2018 $3,370,233, 12.4% December 31, 2017 $2,854,428, 10.6% third
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. 2016 10,000,000 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 December 31, 2018, 11,025,000 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 2009 7,500,000 2009 Each plan is more fully described in “Note 13, ASC 718, Compensation – Stock Compensation ASC 718
Earnings Per Share, Policy [Policy Text Block]	EARNINGS/(LOSS) PER SHARE The Company accounts for Earnings/(loss) Per Share using ASC 260
Income Tax, Policy [Policy Text Block]	INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, Income Taxes. 740 Valuation allowances are established, when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. On December 22, 2017, 21 January 1, 2018. 740, Income Taxes December 31, 2017, 2l 14.
New Accounting Pronouncements, Policy [Policy Text Block]	IMPACT OF NEW ACCOUNTING STANDARDS In February 2016, No. 2016 02, “Leases (Topic 842 )” 2016 02” 12 December 15, 2018. In March 2016, April 2016, December 2016, 2016 08, Revenue from Contracts with Customers - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) 2016 08” 2016 10, Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing 2016 10” 2016 20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers" 2016 20” 2014 09. May 2016, 2016 12, Revenue from Contracts with Customers - Narrow Scope Improvements and Practical Expedients 2014 09, December 15, 2016, not In July 2017, 2017 11 Earnings per Share (Topic 260 ), Distinguishing Liabilities from Equity (Topic 480 ), Derivatives and Hedging (Topic 815 ) 2017 11” 480 not 2017 11 December 15, 2018, 2017 11. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the year ended Revenue activity December 31, 2018 December 31, 2017 Set-up fees $ 3,792,670 $ 4,981,941 Change orders 1,508,248 1,540,167 Maintenance 5,567,039 5,107,787 Software licenses 11,571,134 10,658,977 Professional services 2,917,556 3,359,554 Hosting 1,747,833 1,331,232 Total $ 27,104,480 $ 26,979,658
Allowance for Credit Losses on Financing Receivables [Table Text Block]	December 31, 2018 December 31, 2017 Beginning of period $ 149,980 $ 179,813 Bad debt expense 41,782 130,346 Write-offs (15,542 ) (160,179 ) End of period $ 176,220 $ 149,980
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2018 1 13% 1 20% December 31, 2017 1 10% 1 24%
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	European revenues For the year ended December 31, 2018 December 31, 2017 European revenues % of Total revenues European revenues % of Total revenues $ 4,517,065 17% $ 3,632,537 14%

Note 3 - Earnings (Loss) Per _2

Note 3 - Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Anti-dilutive security December 31, 2018 December 31, 2017 Employee stock options 725,000 4,225,000 Warrants 12,550,000 27,020,000 Convertible notes -0- 11,980,000 Shares issuable for accrued interest 115,677 118,224 Total 13,390,677 43,343,224
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	For the year ended December 31, 2018 December 31, 2017 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 3,687,965 150,832,451 $ 0.02 $ 2,967,218 147,865,246 $ 0.02 Effect of dilutive securities (280,117 ) 13,786,417 (0.02 ) 4,766 312,738 -0- Diluted EPS $ 3,407,848 164,618,868 $ 0.02 $ 2,971,984 148,177,984 $ 0.02

Note 4 - Property and Equipme_2

Note 4 - Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31, 2018 December 31, 2017 Description Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 3,067,069 $ 2,202,166 $ 864,903 $ 2,322,833 $ 1,949,982 $ 372,851 5 Leasehold improvements 136,648 106,362 30,286 118,380 98,901 19,479 5 Computer software 2,426,339 1,991,842 434,497 2,010,999 1,886,342 124,657 3 Office furniture 169,120 138,491 30,629 162,799 127,248 35,551 5 Total $ 5,799,176 $ 4,438,861 $ 1,360,315 $ 4,615,011 $ 4,062,473 $ 552,538

Note 5 - Intangible Assets, N_2

Note 5 - Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2018 December 31, 2017 Asset Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer lists $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer lists 113,220 113,220 -0- 118,780 32,994 85,786 15 Promasys B.V. software code 72,837 72,837 -0- 72,837 60,698 12,139 5 Promasys B.V. URLs/website 57,182 57,182 -0- 59,990 59,990 -0- 3 Acuity software code 1,052,403 321,568 730,835 -0- -0- -0- 3 Total $ 2,688,343 $ 1,957,508 $ 730,835 $ 1,644,308 $ 1,546,383 $ 97,925
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Year Amortization 2019 $ 350,801 2020 350,801 2021 29,233 Total $ 730,835

Note 6 - Accounts Payable and_2

Note 6 - Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Account December 31, 2018 December 31, 2017 Accounts payable $ 895,145 $ 1,303,073 Accrued payroll and related costs 851,530 925,890 Other accrued expenses 250,570 184,131 Accrued interest 72,913 172,951 Total accounts payable and accrued expenses $ 2,070,158 $ 2,586,045

Note 7 - Line of Credit, Note_2

Note 7 - Line of Credit, Notes Payable and Liquidity (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Debt [Table Text Block]	Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2018 Current term Current term 6/30/2016 4/1/2020 10% $ 420,000 $ -0- $ 420,000 $ -0- $ -0- 6/30/2016 4/1/2020 12% 137,500 -0- 137,500 -0- -0- Discount on notes payable -0- (123,184 ) -0- -0- Total $ 557,500 $ -0- $ 434,316 $ -0- $ -0- Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2017 Current term Current term 2/29/2016 4/1/2019 12% $ 400,000 $ -0- $ -0- $ -0- $ 400,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 282,500 -0- 282,500 -0- -0- Discount on notes payable -0- (279,402 ) -0- (117,365 ) Total $ 1,102,500 $ -0- $ 423,098 $ -0- $ 282,635

Note 8 - Convertible Notes Pa_2

Note 8 - Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Maturities of Long-term Debt [Table Text Block]	Year Amount 2019 $ -0- 2020 5,770,000 2021 200,000 Total $ 5,970,000
Convertible Debt [Member]
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2018 Related Non related Related Non related 8/29/2008 4/1/2020 10% $ 1,770,000 $ -0- $ -0- $ 1,770,000 $ -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 5,970,000 $ -0- $ 0 $ 5,770,000 $ 200,000 Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2017 Related Non related Related Non related 8/1/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2019 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 6,170,000 $ -0- $ 50,000 $ 5,770,000 $ 350,000

Note 9 - Fair Value Measureme_2

Note 9 - Fair Value Measurement (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Derivatives: (1) (2) December 31, 2018 (Level 1) (Level 2) (Level 3) Conversion feature liability $ 706,339 $ -0- $ -0- $ 706,339 Warrant liability 1,288,899 -0- -0- 1,288,899 Total of derivative liabilities $ 1,995,238 $ -0- $ -0- $ 1,995,238 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Derivatives: (1) (2) December 31, 2017 (Level 1) (Level 2) (Level 3) Conversion feature liability $ 1,685,947 $ -0- $ -0- $ 1,685,947 Warrant liability 3,440,799 -0- -0- 3,440,799 Total of derivative liabilities $ 5,126,746 $ -0- $ -0- $ 5,126,746
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	Significant valuation assumptions for derivative instruments at December 31, 2018 Risk free interest rate 2.70% to 2.70% Dividend yield 0.00% Expected volatility 92.2% to 97.0% Expected life (range in years) Conversion feature liability 1.25 to 2.25 Warrant liability 0.00 to 2.25 Significant valuation assumptions for derivative instruments at December 31, 2017 Risk free interest rate 1.56% to 1.81% Dividend yield 0.00% Expected volatility 87.0% to 118.4% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25
Fair Value Measurements, Nonrecurring [Table Text Block]	Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Acquired assets (1) December 31, 2017 December 31, 2018 (Level 1) (Level 2) (Level 3) Promasys B.V. customer list (2) (3) $ 85,786 $ -0- $ -0- $ -0- $ 136,253 Promasys B.V. software code (2) 12,139 -0- -0- -0- 72,943 Acuity software code (4) -0- 730,835 -0- -0- 1,052,403 Total $ 97,925 $ 730,835 $ -0- $ -0- $ 1,261,599 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Acquired assets (1) December 30, 2016 December 31, 2017 (Level 1) (Level 2) (Level 3) Promasys B.V. customer list (2) $ 82,173 $ 85,786 $ -0- $ -0- $ 136,253 Promasys B.V. software code (2) 26,707 12,139 -0- -0- 72,943 Total $ 108,880 $ 97,925 $ -0- $ -0- $ 209,196
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block]	Other income/(expense) For the year ended December 31, 2018 December 31, 2017 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date $ 3,111,760 $ 795,779 Total unrealized and realized gains/(losses) included in earnings $ 3,111,760 $ 795,779
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, beginning Net realized Net unrealized and associated with end Derivatives: of year gains/(losses) gains/(losses) settlements convertible debt of year Conversion feature liability $ (1,685,947 ) $ -0- $ 969,108 $ -0- $ 10,500 $ (706,339 ) Warrant liability (3,440,799 ) -0- 2,142,652 9,248 -0- (1,288,899 ) Total of derivative liabilities $ (5,126,746 ) $ -0- $ 3,111,760 $ 9,248 $ 10,500 $ (1,995,238 ) Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, beginning Net realized Net unrealized and associated with end Derivatives: of year gains/(losses) gains/(losses) settlements convertible debt of year Conversion feature liability $ (2,325,730 ) $ 48,375 $ 188,841 $ -0- $ 402,567 $ (1,685,947 ) Warrant liability (3,999,362 ) -0- 558,563 -0- -0- (3,440,799 ) Total of derivative liabilities $ (6,325,092 ) $ 48,375 $ 747,404 $ -0- $ 402,567 $ (5,126,746 )

Note 10 - Commitments and Con_2

Note 10 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Year Payments 2019 $ 655,901 2020 414,973 2021 340,029 2022 340,270 Thereafter 76,243 Total $ 1,827,416
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]	Year Payments 2019 $ 131,067 2020 131,067 2021 52,398 Total minimum capital lease payments 314,532 Less: Amount representing interest (23,682 ) Present value of minimum capital lease payments $ 290,850

Note 12 - Stockholders' (Defi_2

Note 12 - Stockholders' (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule Of Dividends In Arrears [Table Text Block]	Cumulative arrearage Cumulative arrearage per share December 31, December 31, Series of preferred stock 2018 2017 2018 2017 Series B $ 609,887 $ 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 2,081,980
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	December 31, 2018 December 31, 2018 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 – $0.60 22,020,000 1.06 $ 0.45 22,020,000 $ 0.45 December 31, 2017 December 31, 2017 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 – $0.60 27,020,000 1.84 $ 0.42 27,020,000 $ 0.42
Share-based Compensation, Activity [Table Text Block]	Weighted average grant date fair value for the year ended December 31, 2018 2017 Stock options granted during the period $ 0.23 $ 0.21 Stock options vested during the period $ 0.22 $ 0.20 Stock options forfeited during the period $ 0.19 $ 0.13
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Foreign currency translation Accumulated other comprehensive income/(loss) Balance at December 31, 2016 $ (410,505 ) $ (410,505 ) 2017 Activity 13,268 13,268 Balance at December 31, 2017 (397,237 ) (397,237 ) 2018 Activity (39,268 ) (39,268 ) Balance at December 31, 2018 $ (436,505 ) $ (436,505 )
Warrant [Member]
Notes Tables
Share-based Compensation, Activity [Table Text Block]	Warrants Balance at December 31, 2016 27,860,000 Issued -0- Exercised -0- Expired/forfeited (840,000 ) Balance at December 31, 2017 27,020,000 Issued -0- Exercised (4,000,000 ) Expired/forfeited (1,000,000 ) Balance at December 31, 2018 22,020,000 Warrants exercisable at December 31, 2018 22,020,000 Weighted average fair value of warrants granted during 2018 n/a

Note 13 - Employee Equity Inc_2

Note 13 - Employee Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of options Weighted average exercise price Weighted average remaining contractual term Aggregate intrinsic value Outstanding at December 31, 2016 1,225,000 $ 0.17 2.62 $ 83,425 Granted 4,650,000 0.26 Exercised (300,000 ) 0.13 Forfeited/cancelled/expired (300,000 ) 0.14 Outstanding at December 31, 2017 5,275,000 0.26 4.09 $ 130,475 Granted 570,000 0.28 Exercised (300,000 ) 0.21 Forfeited/cancelled/expired (2,975,000 ) 0.25 Outstanding at December 31, 2018 2,570,000 $ 0.28 3.47 $ 16,675 Vested and exercisable at December 31, 2018 887,500 $ 0.25 2.92 $ 14,425
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Fair value of options vesting Number of options vested Fair value of options vested December 31, 2018 812,500 $ 179,978 December 31, 2017 62,500 $ 12,742
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Awards breakdown by price range at December 31, 2018 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 150,000 0.93 $ 0.17 150,000 0.93 $ 0.17 0.21 to 0.30 1,695,000 3.54 0.26 550,000 3.15 0.25 0.31 to 0.50 725,000 3.82 0.34 187,500 3.82 0.34 0.00 to 0.50 2,570,000 3.47 $ 0.28 887,500 2.92 $ 0.25 Awards breakdown by price range at December 31, 2017 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 300,000 1.93 $ 0.18 250,000 1.48 $ 0.17 0.21 to 0.30 4,250,000 4.12 0.25 150,000 1.30 0.22 0.31 to 0.50 725,000 4.82 0.34 -0- 0.00 0.00 0.00 to 0.50 5,275,000 4.09 $ 0.26 400,000 1.42 $ 0.19
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Stock option assumptions for the period ended Stock option assumptions December 31, 2018 December 31, 2017 Risk-free interest rate 2.91% 1.81% Expected dividend yield 0.0% 0.0% Expected volatility 111.0% 127.1% Expected life of options (in years) 5 5
Share-based Compensation, Activity [Table Text Block]	Weighted average grant date fair value for the year ended December 31, 2018 2017 Stock options granted during the period $ 0.23 $ 0.21 Stock options vested during the period $ 0.22 $ 0.20 Stock options forfeited during the period $ 0.19 $ 0.13
Schedule of Nonvested Share Activity [Table Text Block]	Shares underlying stock options Weighted average grant date fair value Nonvested shares at January 1, 2018 4,875,000 $ 0.21 Nonvested shares at December 31, 2018 1,682,500 $ 0.24

Note 14 - Income Taxes (Tables)

Note 14 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	December 31, 2018 December 31, 2017 Federal statutory rate applied to income/(loss) before income taxes $ 1,058,960 $ 1,117,014 Increase/(decrease) in income taxes results from: Current tax expense/(benefit) 490,215 1,194 Nondeductible expenses (582,309 ) (44,845 ) Change in deferred assets 18,354 (35,423 ) Change in valuation allowance (495,005 ) (1,036,746 ) Income tax expense/(benefit) $ 490,215 $ 1,194
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	December 31, 2018 December 31, 2017 Current tax expense/(benefit): $ 490,215 $ 1,194 Deferred tax expense/(benefit): Bad debt allowance (6,651 ) 11,226 Operating loss carryforward 483,302 1,060,942 Amortization of intangibles 18,354 5,482 Patent litigation settlement -0- (40,904 ) 985,220 1,037,940 Valuation allowance (495,005 ) (1,036,746 ) Total tax expense/(benefit) $ 490,215 $ 1,194
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, 2018 December 31, 2017 Amortization of intangibles $ 253,466 $ 261,771 Bad debt allowance 68,133 55,436 Patent litigation liability accrual 359,377 169,709 Impact of the Tax Cuts and Jobs Act -0- (1,699,440 ) Operating loss carryforwards 15,585,125 17,973,631 Gross deferred tax assets 16,266,101 16,761,107 Valuation allowance (16,266,101 ) (16,761,107 ) Net deferred tax liability/(asset) $ -0- $ -0-

Note 1 - Organization and Nat_2

Note 1 - Organization and Nature of Operations (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Research and Development Expense, Total	$ 3,370,233	$ 2,854,428
Revenue Spent on Research and Product Development Activities, Percent	12.40%	10.60%

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Jun. 16, 2016	Jul. 10, 2009
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total	$ (39,268)	$ 13,268
Allowance for Doubtful Accounts Receivable, Current, Ending Balance	176,220	149,980
Cash, Uninsured Amount	861,565
Revenues, Total	27,104,480	26,979,658
Deferred Revenue	8,251,556
Deferred Revenue, Current	6,457,319	7,564,587
Advertising Expense	821,693	701,161
Research and Development Expense, Total	$ 3,370,233	$ 2,854,428
Revenue Spent on Research and Product Development Activities, Percent	12.40%	10.60%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
The 2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	11,025,000		10,000,000
Common Stock Available for Issuance Increasing Period	9 years
Common Stock Available for Issuance, Annual Increase Percent	5.00%
Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized				7,500,000
Leasehold Improvements Computers Equipment And Furniture [Member]
Property, Plant and Equipment, Useful Life	5 years
Software Development [Member]
Property, Plant and Equipment, Useful Life	3 years
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage	13.00%	10.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer 1 [Member]
Concentration Risk, Percentage	13.00%	10.00%
Revenues, Total	$ 3,528,000	$ 2,691,000
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage	20.00%	24.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer 1 [Member]
Concentration Risk, Percentage	20.00%	24.00%
Minimum [Member]
Term Of Software License	3 years
Deferred Revenue, Service Contract Term	30 days
Maximum [Member]
Term Of Software License	5 years
Deferred Revenue, Service Contract Term	6 years 182 days

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies - Revenue by Business Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenues, Total	$ 27,104,480	$ 26,979,658
Set Up Fees [Member]
Revenues, Total	3,792,670	4,981,941
Change Orders [Member]
Revenues, Total	1,508,248	1,540,167
Maintenance 1 [Member]
Revenues, Total	5,567,039	5,107,787
Software Licenses [Member]
Revenues, Total	11,571,134	10,658,977
Professional Services [Member]
Revenues, Total	2,917,556	3,359,554
Hosting [Member]
Revenues, Total	$ 1,747,833	$ 1,331,232

Note 2 - Summary of Significa_5

Note 2 - Summary of Significant Accounting Policies - Allowance for Doubtful Account Summary (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Beginning of period	$ 149,980	$ 179,813
Bad debt expense	41,782	130,346
Write-offs	(15,542)	(160,179)
End of period	$ 176,220	$ 149,980

Note 2 - Summary of Significa_6

Note 2 - Summary of Significant Accounting Policies - Customer Concentration (Details) - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Sales Revenue, Net [Member]
Number of customers	1	1
Concentration Risk, Percentage	13.00%	10.00%
Number of customers	1	1
Concentration risk, percentage	13.00%	10.00%
Accounts Receivable [Member]
Number of customers	1	1
Concentration Risk, Percentage	20.00%	24.00%
Number of customers	1	1
Concentration risk, percentage	20.00%	24.00%

Note 2 - Summary of Significa_7

Note 2 - Summary of Significant Accounting Policies - Revenue From European Operations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
European revenues	$ 27,104,480	$ 26,979,658
Reportable Geographical Components [Member] | Europe [Member]
European revenues	$ 4,517,065	$ 3,632,537
Concentration risk, percentage	17.00%	14.00%

Note 3 - Earnings (Loss) Per _3

Note 3 - Earnings (Loss) Per Share (Details Textual) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Weighted Average Number of Shares Outstanding, Basic, Total	150,832,451	147,865,246
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	13,390,677	43,343,224
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.25
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	0.17
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.25	$ 0.25
Debt Instrument, Convertible, Conversion Price	0.25
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	0.34
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.60	$ 0.60
Debt Instrument, Convertible, Conversion Price	$ 0.50

Note 3 - Earnings (Loss) Per _4

Note 3 - Earnings (Loss) Per Share - Reconciliation of Anti-dilutive Securities (Details) - shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Anti-dilutive Security (in shares)	13,390,677	43,343,224
Employee Stock Option [Member]
Anti-dilutive Security (in shares)	725,000	4,225,000
Warrant [Member]
Anti-dilutive Security (in shares)	12,550,000	27,020,000
Convertible Debt Securities [Member]
Anti-dilutive Security (in shares)	0	11,980,000
Shares Issuable For Accrued Interest [Member]
Anti-dilutive Security (in shares)	115,677	118,224

Note 3 - Earnings (Loss) Per _5

Note 3 - Earnings (Loss) Per Share - Computation of Diluted Earnings Per Share (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Basic EPS, Income (loss) numerator	$ 3,687,965	$ 2,967,218
Weighted Average Number of Shares Outstanding, Basic, Total	150,832,451	147,865,246
Basic EPS, Per-share amount (in dollars per share)	$ 0.02	$ 0.02
Effect of dilutive securities, Income (loss) numerator	$ (280,117)	$ 4,766
Effect of dilutive securities, Shares denominator (in shares)	13,786,417	312,738
Effect of dilutive securities, Per-share amount (in dollars per share)	$ (0.02)	$ 0
Diluted EPS, Income (loss) numerator	$ 3,407,848	$ 2,971,984
Diluted EPS, Shares denominator (in shares)	164,618,868	148,177,984
Diluted EPS, Per-share amount (in dollars per share)	$ 0.02	$ 0.02

Note 4 - Property and Equipme_3

Note 4 - Property and Equipment, Net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Depreciation, Total	$ 398,654	$ 336,102

Note 4 - Property and Equipme_4

Note 4 - Property and Equipment, Net - Property and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cost	$ 5,799,176	$ 4,615,011
Accumulated Depreciation	4,438,861	4,062,473
Net Book Value	1,360,315	552,538
Computer And Office Equipment [Member]
Cost	3,067,069	2,322,833
Accumulated Depreciation	2,202,166	1,949,982
Net Book Value	$ 864,903	372,851
Property, Plant and Equipment, Useful Life	5 years
Leasehold Improvements [Member]
Cost	$ 136,648	118,380
Accumulated Depreciation	106,362	98,901
Net Book Value	$ 30,286	19,479
Property, Plant and Equipment, Useful Life	5 years
Software and Software Development Costs [Member]
Cost	$ 2,426,339	2,010,999
Accumulated Depreciation	1,991,842	1,886,342
Net Book Value	$ 434,497	124,657
Property, Plant and Equipment, Useful Life	3 years
Furniture and Fixtures [Member]
Cost	$ 169,120	162,799
Accumulated Depreciation	138,491	127,248
Net Book Value	$ 30,629	$ 35,551
Property, Plant and Equipment, Useful Life	5 years

Note 5 - Intangible Assets, N_3

Note 5 - Intangible Assets, Net (Details Textual) - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Impairment of Intangible Assets, Finite-lived	$ 79,634	$ 79,634	$ 0
Amortization of Intangible Assets, Total		$ 337,704	$ 22,048

Note 5 - Intangible Assets, N_4

Note 5 - Intangible Assets, Net - Intangible Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cost	$ 2,688,343	$ 1,644,308
Accumulated Amortization	1,957,508	1,546,383
Net Book Value	730,835	97,925
eClinical Customer List [Member]
Cost	1,392,701	1,392,701
Accumulated Amortization	1,392,701	1,392,701
Net Book Value	$ 0	0
Finite-Lived Intangible Asset, Useful Life	3 years
Promasys B.V. Customer List [Member]
Cost	$ 113,220	118,780
Accumulated Amortization	113,220	32,994
Net Book Value	$ 0	85,786
Finite-Lived Intangible Asset, Useful Life	15 years
Promasys B.V. Software Code [Member]
Cost	$ 72,837	72,837
Accumulated Amortization	72,837	60,698
Net Book Value	$ 0	12,139
Finite-Lived Intangible Asset, Useful Life	5 years
Promasys B.V. URLs/Website [Member]
Cost	$ 57,182	59,990
Accumulated Amortization	57,182	59,990
Net Book Value	$ 0	0
Finite-Lived Intangible Asset, Useful Life	3 years
Acuity Software Code [Member]
Cost	$ 1,052,403	0
Accumulated Amortization	321,568	0
Net Book Value	$ 730,835	$ 0
Finite-Lived Intangible Asset, Useful Life	3 years

Note 5 - Intangible Assets, N_5

Note 5 - Intangible Assets, Net - Intangible Assets, Future Amortization Expense (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
2019	$ 350,801
2020	350,801
2021	29,233
Total	$ 730,835	$ 97,925

Note 6 - Accounts Payable and_3

Note 6 - Accounts Payable and Accrued Expenses - Accounts Payable and Accrued Expenses (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Accounts payable	$ 895,145	$ 1,303,073
Accrued payroll and related costs	851,530	925,890
Other accrued expenses	250,570	184,131
Accrued interest	72,913	172,951
Total accounts payable and accrued expenses	$ 2,070,158	$ 2,586,045

Note 7 - Line of Credit, Note_3

Note 7 - Line of Credit, Notes Payable and Liquidity (Details Textual) - USD ($)	Dec. 31, 2018	Dec. 27, 2018	Aug. 31, 2017	Dec. 05, 2016	Jun. 30, 2016	Feb. 29, 2016	Mar. 18, 2013	Dec. 31, 2018	Dec. 31, 2017	Feb. 03, 2015	Dec. 18, 2013
Line of Credit Facility, Maximum Borrowing Capacity							$ 2,000,000			$ 5,000,000	$ 4,000,000
Debt Instrument, Interest Rate, Stated Percentage							2.00%
Debt Instrument, Periodic Payment, Interest							$ 9,500
Long-term Line of Credit, Total	$ 2,900,000							$ 2,900,000
Line of Credit Facility, Interest Rate at Period End	4.50%							4.50%
Unsecured Debt, Total	$ 557,500							$ 557,500	$ 1,102,500
Warrants and Rights Exercised								$ 400,000	$ 0
Class of Warrant or Right, Exercised During Period								(4,000,000)	0
Matures on April 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage						12.00%
Debt Instrument, Face Amount						$ 450,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,000,000				1,800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.25				$ 0.25
Extinguishment of Debt, Amount			$ 400,000			$ 450,000
Warrants Sold During the Period				1,000,000
Warrants and Rights Exercised		$ 400,000
Class of Warrant or Right, Exercised During Period		1,600,000
Warrants and Rights Outstanding						325,689
Debt Instrument, Fair Value Disclosure, Total						$ 124,311
Amortization Period of Warrant Liabilities						3 years 30 days
Matures April 1, 2020 I [Member] | Investor [Member]
Debt Instrument, Interest Rate, Stated Percentage					12.00%
Debt Instrument, Face Amount					$ 372,500
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					1,490,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.25
Warrants and Rights Outstanding					$ 246,921
Debt Instrument, Fair Value Disclosure, Total					$ 125,579
Amortization Period of Warrant Liabilities					3 years 270 days
Repayments of Long-term Debt, Total	$ 145,000		$ 90,000
Matures April 1, 2020 II [Member] | Investor [Member]
Debt Instrument, Interest Rate, Stated Percentage					10.00%
Debt Instrument, Face Amount					$ 420,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					1,680,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.25
Warrants and Rights Outstanding					$ 278,408
Debt Instrument, Fair Value Disclosure, Total					$ 141,592
Amortization Period of Warrant Liabilities					3 years 270 days

Note 7 - Line of Credit, Note_4

Note 7 - Line of Credit, Notes Payable and Liquidity - Notes Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Mar. 18, 2013
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Ending principal	$ 557,500	$ 1,102,500
Discount on notes payable
Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0	0
Discount on notes payable	0	0
Short-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Discount on notes payable	0	0
Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	434,316	423,098
Discount on notes payable	(123,184)	(279,402)
Long-term Debt [Member] | Related Party [Member]
Ending principal	0	282,635
Discount on notes payable	$ 0	$ (117,365)
Notes Payable, Matures April 1, 2020 I [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Ending principal	$ 420,000	$ 420,000
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	420,000	420,000
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal	$ 0	$ 0
Notes Payable, Matures April 1, 2019 [Member]
Maturity date		Apr. 1, 2019
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Ending principal		$ 400,000
Notes Payable, Matures April 1, 2019 [Member] | Short-term Debt [Member] | Non-Related Party Current [Member]
Ending principal		0
Notes Payable, Matures April 1, 2019 [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2019 [Member] | Long-term Debt [Member] | Non-Related Party Current [Member]
Ending principal		0
Notes Payable, Matures April 1, 2019 [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal		$ 400,000
Notes Payable, Matures April 1, 2020 II [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Ending principal	$ 137,500	$ 282,500
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	137,500	282,500
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal	$ 0	$ 0

Note 8 - Convertible Notes Pa_3

Note 8 - Convertible Notes Payable (Details Textual) - USD ($)

Dec. 27, 2018

Sep. 30, 2018

Jun. 30, 2018

Aug. 31, 2017

Jun. 30, 2017

Dec. 14, 2016

Feb. 29, 2016

Nov. 23, 2015

Nov. 19, 2015

May 01, 2015

Mar. 30, 2011

Sep. 30, 2009

Dec. 31, 1999

Aug. 31, 2017

Aug. 29, 2008

Sep. 30, 2018

Dec. 31, 2018

Dec. 31, 2017

Jun. 30, 2016

Jun. 30, 2015

May 07, 2015

Apr. 30, 2015

Apr. 27, 2015

Apr. 01, 2015

Jan. 31, 2015

Jul. 31, 2014

Apr. 28, 2014

Apr. 21, 2014

Dec. 31, 2013

Mar. 18, 2013

Mar. 12, 2013

Mar. 06, 2013

Feb. 27, 2013

Feb. 22, 2013

Dec. 16, 2008

Jun. 30, 2008

Jun. 30, 2004

Debt Instrument, Interest Rate, Stated Percentage

2.00%

Convertible Notes Payable, Total

$ 5,970,000

$ 6,170,000

Interest Paid, Excluding Capitalized Interest, Operating Activities

1,144,586

1,051,909

Repayments of Notes Payable

345,000

915,000

Repayments of Related Party Debt

$ 0

$ 105,000

Director Mr. Wit [Member]

Class of Warrant or Right Cancelled During the Period

1,900,000

Chief Executive Officer [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

2,000,000

1,800,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

$ 0.25

Repayments of Notes Payable

$ 50,000

Extinguishment of Debt, Amount

$ 400,000

Convertible Notes 10% [Member]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Convertible Notes Payable, Total

$ 862,500

Payments of Debt Issuance Costs

119,625

Proceeds from Issuance of Debt

$ 742,875

Debt Instrument, Convertible, Conversion Price

$ 1.25

Repayments of Convertible Debt

$ 50,000

Interest Paid, Excluding Capitalized Interest, Operating Activities

96,949

Debt Conversion, Converted Instrument, Amount

$ 862,500

Debt Conversion, Converted Instrument, Shares Issued

1,495,179

Long-term Debt, Gross

$ 0

$ 0

Secured Convertible Debenture [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Notes Payable, Total

$ 1,400,000

Proceeds from Issuance of Secured Debt

$ 1,400,000

Repayments of Notes Payable

$ 200,000

Secured Convertible Debenture [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

1,200,000

Secured Convertible Debenture [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Convertible Notes Payable, Total

$ 1,100,000

$ 1,100,000

$ 1,100,000

Debt Instrument, Convertible, Conversion Price

$ 0.25

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

5,600,000

Long-term Debt, Term

4 years

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

Secured Convertible Debenture [Member] | Lenders [Member]

Repayments of Convertible Debt

$ 100,000

$ 625,000

Secured Convertible Debenture [Member] | Lenders [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

$ 625,000

$ 100,000

1,200,000

Secured Convertible Debenture [Member] | Director Mr. Wit [Member]

Debt Conversion, Converted Instrument, Amount

$ 475,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,900,000

Extinguishment of Debt, Amount

$ 475,000

Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares

1,900,000

Increase (Decrease) in Notes Payable, Related Parties

$ 625,000

Convertible Debentures Issued August 2008 [Member]

Convertible Notes Payable, Total

$ 2,270,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

1,770,000

1,770,000

Convertible Debentures Issued August 2008 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Convertible, Conversion Price

$ 0.50

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

4,540,000

Convertible Debentures Issued August 2008 [Member] | Mr. van Kesteren and Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

$ 1,920,000

150,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Non-Related Party [Member]

Convertible Notes Payable, Total

$ 150,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable, Total

$ 150,000

Convertible Debentures [Member] | Director Mr. Wit [Member]

Convertible Notes Payable, Total

$ 510,000

Debt Conversion, Converted Instrument, Amount

$ 510,000

Convertible Debentures [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Convertible Notes Payable, Total

$ 150,000

Matures April 1, 2020 I [Member] | Director Mr. Wit [Member]

Convertible Notes Payable, Total

4,055,000

Repayments of Convertible Debt

55,000

Matures April 1, 2020 I [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable, Total

1,770,000

Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Convertible Notes Payable, Total

160,000

Repayments of Convertible Debt

$ 160,000

Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable, Total

150,000

Matures on April 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

2,000,000

1,800,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

$ 0.25

Extinguishment of Debt, Amount

400,000

$ 450,000

Matures on April 1, 2019 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable, Total

150,000

Repayments of Convertible Debt

$ 150,000

Convertible Debentures Issued December 2008 [Member]

Convertible Notes Payable, Total

$ 5,075,000

Convertible Debentures Issued December 2008 [Member] | Non-Related Party [Member]

Convertible Notes Payable, Total

$ 160,000

Convertible Debentures Issued December 2008 [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

$ 360,000

Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Repayments of Notes Payable

55,000

Convertible Debentures Issued December 2008 [Member] | Lenders [Member]

Convertible Notes Payable, Total

$ 100,000

$ 200,000

Convertible Debentures Issued December 2008 [Member] | Lenders [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

$ 100,000

$ 100,000

$ 200,000

4,505,000

Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,680,000

Class of Warrant or Right Cancelled During the Period

1,680,000

Extinguishment of Debt, Amount

$ 420,000

Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

$ 4,475,000

Convertible Debentures Issued December 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

$ 160,000

$ 160,000

Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer, Director, Chief Operating Officer, Chairman, Chief Technology Officer, Chief Financial Officer and Directors [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Debt Instrument, Convertible, Conversion Price

$ 0.50

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

10,150,000

Convertible Debentures Issued December 2008 [Member] | Officers, Directors and Affiliate [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

$ 4,980,000

Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer [Member]

Convertible Notes Payable, Total

4,475,000

Convertible Debentures Issued December 2008 [Member] | Chief Operating Officer [Member]

Convertible Notes Payable, Total

25,000

Convertible Debentures Issued December 2008 [Member] | Chairman and Chief Technology Officer [Member]

Convertible Notes Payable, Total

$ 5,000

Convertible Debentures Issued December 2008 [Member] | Chief Financial Officer [Member]

Repayments of Related Party Debt

$ 5,000

Convertible Debentures Issued December 2008 [Member] | Former Director [Member]

Convertible Notes Payable, Total

$ 15,000

Repayments of Convertible Debt

15,000

Convertible Debentures Issued December 2008 [Member] | Former Director [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable, Total

$ 15,000

Convertible Debentures Issued December 2008 [Member] | President [Member]

Convertible Notes Payable, Total

$ 25,000

Repayments of Convertible Debt

$ 25,000

Matures April 1, 2020 II [Member] | Lenders [Member]

Convertible Notes Payable, Total

$ 100,000

Repayments of Debt

$ 100,000

Matures April 2021 [Member] | Lenders [Member]

Convertible Notes Payable, Total

$ 200,000

Note 8 - Convertible Notes Pa_4

Note 8 - Convertible Notes Payable - Convertible Debt (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Mar. 18, 2013
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Convertible Notes Payable, Total	$ 5,970,000	$ 6,170,000
Convertible notes payable, short term	0	50,000
Convertible notes payable, related parties, long term	5,770,000	5,770,000
Convertible notes payable, long term	200,000	350,000
Related Party [Member]
Convertible notes payable, short term	0	0
Convertible notes payable, related parties, long term	5,770,000	5,770,000
Non-Related Party [Member]
Convertible notes payable, short term	0	50,000
Convertible notes payable, long term	$ 200,000	$ 350,000
Convertible Notes Payable 10% $150,000 [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2019
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Convertible Notes Payable, Total	$ 1,770,000	$ 150,000
Convertible Notes Payable 10% $150,000 [Member] | Related Party [Member]
Convertible notes payable, short term	0	0
Convertible notes payable, related parties, long term	1,770,000	0
Convertible Notes Payable 10% $150,000 [Member] | Non-Related Party [Member]
Convertible notes payable, short term	0	0
Convertible notes payable, long term	$ 0	$ 150,000
Convertible Notes Payable 10% $50,000 [Member]
Maturity date		Jun. 30, 2004
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Convertible Notes Payable, Total		$ 50,000
Convertible Notes Payable 10% $50,000 [Member] | Related Party [Member]
Convertible notes payable, short term		0
Convertible notes payable, related parties, long term		0
Convertible Notes Payable 10% $50,000 [Member] | Non-Related Party [Member]
Convertible notes payable, short term		50,000
Convertible notes payable, long term		$ 0
Convertible Notes Payable12 Percent, 200,000 [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Convertible Notes Payable, Total	$ 4,000,000	$ 4,000,000
Convertible Notes Payable12 Percent, 200,000 [Member] | Related Party [Member]
Convertible notes payable, short term	0	0
Convertible notes payable, related parties, long term	4,000,000	4,000,000
Convertible Notes Payable12 Percent, 200,000 [Member] | Non-Related Party [Member]
Convertible notes payable, short term	0	0
Convertible notes payable, long term	$ 0	$ 0
Convertible Notes Payable 12 Percent,100,000 [Member]
Maturity date	Apr. 1, 2021	Apr. 1, 2021
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Convertible Notes Payable, Total	$ 200,000	$ 200,000
Convertible Notes Payable 12 Percent,100,000 [Member] | Related Party [Member]
Convertible notes payable, short term	0	0
Convertible notes payable, related parties, long term	0	0
Convertible Notes Payable 12 Percent,100,000 [Member] | Non-Related Party [Member]
Convertible notes payable, short term	0	0
Convertible notes payable, long term	$ 200,000	$ 200,000
Convertible Notes Payable 10% $1,770,000 [Member]
Maturity date		Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Convertible Notes Payable, Total		$ 1,770,000
Convertible Notes Payable 10% $1,770,000 [Member] | Related Party [Member]
Convertible notes payable, short term		0
Convertible notes payable, related parties, long term		1,770,000
Convertible Notes Payable 10% $1,770,000 [Member] | Non-Related Party [Member]
Convertible notes payable, short term		0
Convertible notes payable, long term		$ 0

Note 8 - Convertible Notes Pa_5

Note 8 - Convertible Notes Payable - Convertible Debt Maturity Payments (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Total	$ 5,970,000	$ 6,170,000
Convertible Debt [Member]
2019	0
2020	5,770,000
2021	200,000
Total	$ 5,970,000

Note 9 - Fair Value Measureme_3

Note 9 - Fair Value Measurement (Details Textual) - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Impairment of Intangible Assets, Finite-lived	$ 79,634	$ 79,634	$ 0
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life		3 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life		15 years

Note 9 - Fair Value Measureme_4

Note 9 - Fair Value Measurement - Fair Value of Liabilities Measured on a Recurring Basis (Details) - Fair Value, Measurements, Recurring [Member] - USD ($)		Dec. 31, 2018	Dec. 31, 2017
Derivative Liability fair value	[1],[2]	$ 1,995,238	$ 5,126,746
Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1],[2]	0	0
Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1],[2]	0	0
Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1],[2]	1,995,238	5,126,746
Conversion Feature Liability [Member]
Derivative Liability fair value	[1],[2]	706,339	1,685,947
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1],[2]	0	0
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1],[2]	0	0
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1],[2]	706,339	1,685,947
Warrant Liability [Member]
Derivative Liability fair value	[1],[2]	1,288,899	3,440,799
Warrant Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1],[2]	0	0
Warrant Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1],[2]	0	0
Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1],[2]	$ 1,288,899	$ 3,440,799
[1]	The fair value at the measurement date is equal to the carrying value on the balance sheet.
[2]	The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2018.

Note 9 - Fair Value Measureme_5

Note 9 - Fair Value Measurement - Fair Value Assumptions (Details)	Dec. 31, 2018	Dec. 31, 2017
Measurement Input, Expected Dividend Rate [Member]
Risk free interest rate	0	0
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Risk free interest rate	0.027	0.0156
Minimum [Member] | Measurement Input, Price Volatility [Member]
Risk free interest rate	0.922	0.87
Minimum [Member] | Measurement Input, Expected Term [Member] | Conversion Feature Liability [Member]
Risk free interest rate	1.25	1.25
Minimum [Member] | Measurement Input, Expected Term [Member] | Warrant Liability [Member]
Risk free interest rate	0	0.25
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Risk free interest rate	0.027	0.0181
Maximum [Member] | Measurement Input, Price Volatility [Member]
Risk free interest rate	0.97	1.184
Maximum [Member] | Measurement Input, Expected Term [Member] | Conversion Feature Liability [Member]
Risk free interest rate	2.25	3.25
Maximum [Member] | Measurement Input, Expected Term [Member] | Warrant Liability [Member]
Risk free interest rate	2.25	3.25

Note 9 - Fair Value Measureme_6

Note 9 - Fair Value Measurement - Fair Value of Assets Acquired on Non-recurring Basis (Details) - Fair Value, Measurements, Nonrecurring [Member] - USD ($)		Dec. 31, 2018		Dec. 31, 2017	Dec. 30, 2016
Reported Value Measurement [Member]
Acquired assets	[1]	$ 730,835		$ 97,925	$ 108,880
Reported Value Measurement [Member] | Promasys B.V. Customer List [Member]
Acquired assets	[1],[3]	0	[2]	85,786	82,173
Reported Value Measurement [Member] | Promasys B.V. Software Code [Member]
Acquired assets	[1],[3]	0		12,139	$ 26,707
Reported Value Measurement [Member] | Acuity Software Code [Member]
Acquired assets	[1],[4]	730,835		0
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Acquired assets	[1]	0		0
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]
Acquired assets	[1]	0		0
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Acquired assets	[1]	1,261,599		209,196
Estimate of Fair Value Measurement [Member] | Promasys B.V. Customer List [Member] | Fair Value, Inputs, Level 1 [Member]
Acquired assets	[1],[3]	0	[2]	0
Estimate of Fair Value Measurement [Member] | Promasys B.V. Customer List [Member] | Fair Value, Inputs, Level 2 [Member]
Acquired assets	[1],[3]	0	[2]	0
Estimate of Fair Value Measurement [Member] | Promasys B.V. Customer List [Member] | Fair Value, Inputs, Level 3 [Member]
Acquired assets	[1],[3]	136,253	[2]	136,253
Estimate of Fair Value Measurement [Member] | Promasys B.V. Software Code [Member] | Fair Value, Inputs, Level 1 [Member]
Acquired assets	[1],[3]	0		0
Estimate of Fair Value Measurement [Member] | Promasys B.V. Software Code [Member] | Fair Value, Inputs, Level 2 [Member]
Acquired assets	[1],[3]	0		0
Estimate of Fair Value Measurement [Member] | Promasys B.V. Software Code [Member] | Fair Value, Inputs, Level 3 [Member]
Acquired assets	[1],[3]	72,943		$ 72,943
Estimate of Fair Value Measurement [Member] | Acuity Software Code [Member] | Fair Value, Inputs, Level 1 [Member]
Acquired assets	[1],[4]	0
Estimate of Fair Value Measurement [Member] | Acuity Software Code [Member] | Fair Value, Inputs, Level 2 [Member]
Acquired assets	[1],[4]	0
Estimate of Fair Value Measurement [Member] | Acuity Software Code [Member] | Fair Value, Inputs, Level 3 [Member]
Acquired assets	[1],[4]	$ 1,052,403
[1]	The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied.
[2]	During the second quarter of 2018 we recognized an impairment loss of $79,634 on the Promasys B.V. Customer List after performing a fair value analysis on the asset utilizing a discounted cash flow model. The impairment charge is separately presented on the Statement of Operations.
[3]	The acquired Promasys B.V. software code and customer list are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead, the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction.
[4]	The acquired Acuity software code is not measured on a recurring basis since the initial fair value has been deemed to have a finite life and is being amortized periodically. Instead, the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction.

Note 9 - Fair Value Measureme_7

Note 9 - Fair Value Measurement - Unrealized Gain or Loss Included in Earnings (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date	$ 3,111,760	$ 795,779

Note 9 - Fair Value Measureme_8

Note 9 - Fair Value Measurement - Change in Level 3 Financial Liabilities Fair Value (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Balance, beginning of year	$ (5,126,746)	$ (6,325,092)
Net realized gains/(losses)	0	48,375
Net unrealized gains/(losses) relating to instruments still held at the reporting date	3,111,760	747,404
Net purchases, issuances and settlements	9,248	0
Net transfers in and/or out of Level 3	10,500	402,567
Balance, end of period	(1,995,238)	(5,126,746)
Conversion Feature Liability [Member]
Balance, beginning of year	(1,685,947)	(2,325,730)
Net realized gains/(losses)	0	48,375
Net unrealized gains/(losses) relating to instruments still held at the reporting date	969,108	188,841
Net purchases, issuances and settlements	0	0
Net transfers in and/or out of Level 3	10,500	402,567
Balance, end of period	(706,339)	(1,685,947)
Warrant Liability [Member]
Balance, beginning of year	(3,440,799)	(3,999,362)
Net realized gains/(losses)	0	0
Net unrealized gains/(losses) relating to instruments still held at the reporting date	2,142,652	558,563
Net purchases, issuances and settlements	9,248	0
Net transfers in and/or out of Level 3	0	0
Balance, end of period	$ (1,288,899)	$ (3,440,799)

Note 10 - Commitments and Con_3

Note 10 - Commitments and Contingencies (Details Textual) - USD ($)	Dec. 31, 2017	Jun. 23, 2009	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2017
Operating Leases, Rent Expense, Total			$ 1,254,087	$ 1,125,147
License Payments		$ 300,000
Additional Income (Expense) Related to Settlement Agreement			$ 0	$ 108,702
Settlement and Licensing Agreement [Member]
Patent Royalty Percentage Obligation					2.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	1,000,000			1,000,000	1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.01			$ 0.01	$ 0.01
Loss Contingency, Estimate of Possible Loss	$ 300,000			$ 300,000	$ 300,000
Class of Warrant or Right, Percentage, Exercised for Stock	50.00%
Stock Issued During Period, Shares, Exercise of Warrants	500,000
Class of Warrant or Right, Percentage, Exercised for Cash Payment	50.00%
Proceeds from Warrant Exercises	$ 145,000
Computer Equipment [Member]
Property, Plant and Equipment, Useful Life			5 years

Note 10 - Commitments and Con_4

Note 10 - Commitments and Contingencies - Future Minimum Lease Payments (Details)	Dec. 31, 2018USD ($)
2019	$ 655,901
2020	414,973
2021	340,029
2022	340,270
Thereafter	76,243
Total	$ 1,827,416

Note 10 - Commitments and Con_5

Note 10 - Commitments and Contingencies - Future Minimum Capital Lease Payments (Details)	Dec. 31, 2018USD ($)
2019	$ 131,067
2020	131,067
2021	52,398
Total minimum capital lease payments	314,532
Less: Amount representing interest	(23,682)
Present value of minimum capital lease payments	$ 290,850

Note 11 - Related Party Trans_2

Note 11 - Related Party Transactions (Details Textual) - USD ($)	Dec. 27, 2018	Aug. 31, 2017	Apr. 07, 2017	Nov. 19, 2015	Dec. 16, 2008	Aug. 29, 2008	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2016	Feb. 29, 2016	Feb. 03, 2015	Jan. 31, 2015	Dec. 31, 2013	Dec. 18, 2013	Mar. 18, 2013	Feb. 22, 2013	Oct. 16, 2012	Sep. 30, 2009	Jun. 30, 2008	Feb. 29, 2008
Convertible Notes Payable, Total							$ 5,970,000	$ 6,170,000
Debt Instrument, Interest Rate, Stated Percentage															2.00%
Repayments of Notes Payable							345,000	915,000
Warrants and Rights Exercised							400,000	0
Line of Credit Facility, Maximum Borrowing Capacity											$ 5,000,000			$ 4,000,000	$ 2,000,000
Long-term Line of Credit, Total							$ 2,900,000
Line of Credit Facility, Interest Rate at Period End							4.50%
Interest Expense, Related Party							$ 935,839	$ 947,688
Class of Warrant or Right, Exercised During Period							(4,000,000)	0
The Northern Trust Company [Member]
Line of Credit Facility, Maximum Borrowing Capacity											$ 5,000,000			$ 4,000,000	$ 2,000,000
Line of Credit Facility, Interest Rate During Period			2.00%
Long-term Line of Credit, Total							$ 2,900,000
Line of Credit Facility, Interest Rate at Period End							4.50%
Director Mr. Wit [Member]
Class of Warrant or Right Cancelled During the Period				1,900,000
Interest Expense, Related Party Approximately Monthly Amount			$ 9,500
Chief Executive Officer [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	2,000,000									1,800,000
Debt Instrument, Interest Rate, Stated Percentage										12.00%
Notes Payable, Related Parties										$ 450,000
Extinguishment of Debt, Amount	$ 400,000
Repayments of Notes Payable		$ 50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25									$ 0.25
Interest Payable										$ 450,000
Warrants and Rights Exercised	$ 400,000
Class of Warrant or Right, Exercised During Period	1,600,000
Convertible Debentures [Member] | Director Mr. Wit [Member]
Due to Related Parties, Total							$ 5,770,000
Convertible Notes Payable, Total																			$ 510,000
Debt Conversion, Converted Instrument, Amount						$ 510,000
Convertible Debenture Initiated In June 2008 [Member] | Director Mr. Wit [Member]
Convertible Notes Payable, Total						$ 1,260,000			$ 1,770,000			$ 1,770,000				$ 1,770,000		$ 1,770,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						3,540,000
Debt Instrument, Interest Rate, Stated Percentage						10.00%
Debt Instrument, Convertible, Conversion Price						$ 0.50
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member]
Convertible Notes Payable, Total												4,475,000				4,475,000	$ 125,000	$ 4,350,000		$ 4,200,000
Debt Conversion, Converted Instrument, Amount					$ 4,350,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,680,000	8,700,000												250,000
Debt Instrument, Convertible, Conversion Price					$ 0.50
Notes Payable, Related Parties																				$ 150,000
Debt Conversion, Converted Instrument, Rate					12.00%
Extinguishment of Debt, Amount				$ 420,000
Class of Warrant or Right Cancelled During the Period				1,680,000
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]
Convertible Notes Payable, Total									$ 4,055,000
Convertible Debentures Issued December 2008 [Member]
Convertible Notes Payable, Total					$ 5,075,000
Convertible Debentures Issued December 2008 [Member] | Extended Maturity Debentures [Member]
Convertible Notes Payable, Total													$ 360,000
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,680,000
Extinguishment of Debt, Amount				$ 420,000
Class of Warrant or Right Cancelled During the Period				1,680,000
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]
Convertible Notes Payable, Total												$ 4,475,000
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Repayments of Notes Payable		$ 55,000
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer [Member]
Convertible Notes Payable, Total																$ 4,475,000

Note 12 - Stockholders' (Defi_3

Note 12 - Stockholders' (Deficit) (Details Textual)	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 27, 2018$ / sharesshares	Oct. 28, 2018shares	Sep. 06, 2018shares	Jun. 15, 2018shares	May 16, 2018shares	Jan. 30, 2018shares	Dec. 31, 2017$ / sharesshares	Sep. 29, 2017shares	Aug. 02, 2017shares	Jun. 26, 2017shares	Mar. 24, 2017shares	Dec. 31, 2015shares	Apr. 30, 2016shares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2015shares	Dec. 31, 2014shares	Dec. 31, 1999shares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 31, 2016shares	Dec. 30, 2016shares	Nov. 30, 2010shares	Mar. 31, 2002shares	Feb. 28, 2002shares	Aug. 31, 2001shares
Common Stock, Shares Authorized	500,000,000							500,000,000							500,000,000	500,000,000				500,000,000
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.001							$ 0.001							$ 0.001	$ 0.001				$ 0.001
Preferred Stock, Shares Authorized	10,000,000														10,000,000					10,000,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001														$ 0.001					$ 0.001
Common Stock, Shares, Issued, Total	155,368,647							148,542,805							155,368,647	148,542,805				155,368,647
Class of Warrant or Right, Issued	22,020,000														22,020,000					22,020,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued, Number	2,570,000														2,570,000					2,570,000
Convertible Debt, Total | $	$ 5,970,000														$ 5,970,000					$ 5,970,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period															300,000	300,000
Preferred Stock, Amount of Preferred Dividends in Arrears | $															$ 2,081,980	$ 2,081,980
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares
Common Stock, Shares, Outstanding, Ending Balance	155,368,647							148,542,805							155,368,647	148,542,805				155,368,647
Class of Warrant or Right, Outstanding	22,020,000							27,020,000							22,020,000	27,020,000				22,020,000		27,860,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	2,570,000							5,275,000							2,570,000	5,275,000				2,570,000	1,225,000
Conversion of Series A Preferred Stock into Common Shares [Member]
Conversion of Stock, Shares Converted														3,637,724
Stock Issued During Period, Shares, Conversion of Convertible Securities														14,615,696
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period															200,000	250,000
Stock Issued During Period, Shares, Exercise of Warrants															4,000,000	500,000
Stock Issued During Period, Shares, Purchase of Assets															1,666,667
Conversion of Stock, Shares Converted																	487,500
Stock Issued During Period, Shares, Conversion of Convertible Securities																	1,950,000
DataSci [Member]
Class of Warrant or Right, Percentage, Exercised for Stock								50.00%
Stock Issued During Period, Shares, Exercise of Warrants								500,000
Algorithm [Member]
Stock Issued During Period, Shares, Purchase of Assets							1,666,667
Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period					100,000	100,000			50,000	100,000	22,556
Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period									100,000
Stock Issued During Period, Shares, Exercise of Warrants	1,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	1,000,000														1,000,000					1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.25														$ 0.25					$ 0.25
Chief Operating Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			34,175
Board of Directors Chairman [Member]
Stock Issued During Period, Shares, Exercise of Warrants		2,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.25
Chief Technology Officer [Member]
Stock Issued During Period, Shares, Exercise of Warrants		1,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.25
Restricted Stock [Member] | Former Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period												16,668
Restricted Stock [Member] | Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				225,000
Restricted Stock [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				225,000
Restricted Stock [Member] | Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technology Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	600,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				900,000
Restricted Stock [Member] | Board of Director One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				200,000
Restricted Stock [Member] | Five Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	375,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				1,000,000
Restricted Stock [Member] | Chief Operating Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				225,000
Restricted Stock [Member] | Chief Technology Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				225,000
Restricted Stock [Member] | Board of Director Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				200,000
Restricted Stock [Member] | Board of Director Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				200,000
Restricted Stock [Member] | Board of Director Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				200,000
Restricted Stock [Member] | Board of Director Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				200,000
Conversion of Conversion Debt into Common Stock [Member]
Debt Instrument, Convertible, Number of Equity Instruments															11,940,000
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized	5,000,000														5,000,000				5,000,000	5,000,000
Preferred Stock, Dividend Rate, Percentage															5.00%		5.00%	5.00%	5.00%
Preferred Stock, Shares Issued, Total	0														0					0
Convertible Preferred Stock, Conversion Price | $ / shares															$ 1.11
Convertible Preferred Stock, Conversion Term															1 year
Convertible Preferred Stock, Stock Price Trigger | $ / shares															$ 3
Convertible Preferred Stock, Threshold Consecutive Trading Days															20 days
Preferred Stock, Redemption Price Per Share | $ / shares	$ 1														$ 1					$ 1
Preferred Stock, Liquidation Preference Per Share | $ / shares	$ 1														$ 1					$ 1
Voting Rights, Number of Votes															1
Conversion of Stock, Shares Converted																		235,000
Number of Shareholders, Exchange Offer Initiated													34
Convertible Preferred Stock, Shares Issued upon Conversion													4				4
Number of Shareholders, Exchange Offer Accepted																	4
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized	230,000							230,000							230,000	230,000				230,000					230,000	200,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001							$ 0.001							$ 0.001	$ 0.001				$ 0.001
Preferred Stock, Dividend Rate, Percentage															8.00%
Preferred Stock, Shares Outstanding, Ending Balance	0							0							0	0				0
Preferred Stock, Shares Issued, Total	0							0							0	0				0
Convertible Preferred Stock, Stock Price Trigger | $ / shares															$ 0.50
Convertible Preferred Stock, Threshold Consecutive Trading Days															20 days
Preferred Stock, Redemption Price Per Share | $ / shares	$ 10														$ 10					$ 10
Preferred Stock, Liquidation Preference Per Share | $ / shares	10														$ 10					10
Voting Rights, Number of Votes															1
Conversion of Stock, Shares Converted															200,000
Share Price | $ / shares	$ 0.25														$ 0.25					$ 0.25
Convertible Preferred Stock, Public Offering Proceeds Threshold | $															$ 25,000,000
Preferred Stock, Amount of Preferred Dividends in Arrears | $															$ 609,887	$ 609,887
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares															$ 3.05	$ 3.05
Voting Rights, Number of Members of Board of Congress															1
Series C Preferred Stock [Member]
Preferred Stock, Shares Authorized	747,500							747,500							747,500	747,500				747,500				747,500
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001							$ 0.001							$ 0.001	$ 0.001				$ 0.001
Preferred Stock, Dividend Rate, Percentage															8.00%
Preferred Stock, Shares Outstanding, Ending Balance	0							0							0	0				0
Preferred Stock, Shares Issued, Total	0							0							0	0				0
Convertible Preferred Stock, Threshold Consecutive Trading Days															20 days
Preferred Stock, Redemption Price Per Share | $ / shares	$ 10														$ 10					$ 10
Preferred Stock, Liquidation Preference Per Share | $ / shares	10														$ 10					$ 10
Voting Rights, Number of Votes															1
Conversion of Stock, Shares Converted																				337,150
Share Price | $ / shares	$ 0.25														$ 0.25					$ 0.25
Convertible Preferred Stock, Public Offering Proceeds Threshold | $															$ 25,000,000
Preferred Stock, Amount of Preferred Dividends in Arrears | $															$ 1,472,093	$ 1,472,093
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares															$ 4.37	$ 4.37
Voting Rights, Number of Members of Board of Congress															2
Convertible Preferred Stock, Offering Price Threshold Ratio															2.5
Series D Preferred Stock [Member]
Preferred Stock, Shares Authorized	250,000							250,000							250,000	250,000				250,000			250,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001							$ 0.001							$ 0.001	$ 0.001				$ 0.001
Preferred Stock, Shares Outstanding, Ending Balance	250,000							250,000							250,000	250,000				250,000
Preferred Stock, Shares Issued, Total	250,000							250,000							250,000	250,000				250,000
Preferred Stock, Liquidation Preference Per Share | $ / shares	$ 0.001														$ 0.001					$ 0.001
Voting Rights, Number of Votes															400
Preferred Stock, Right of First Refusal															30 days
Convertible Series B Preferred Stock [Member]
Share Price | $ / shares	$ 0.75														$ 0.75					$ 0.75

Note 12 - Stockholders' (Defi_4

Note 12 - Stockholders' (Deficit) - Cumulative Arrearage of Undeclared Dividends (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 2,081,980	$ 2,081,980
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears
Series B Preferred Stock [Member]
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 609,887	$ 609,887
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 3.05	$ 3.05
Series C Preferred Stock [Member]
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 1,472,093	$ 1,472,093
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 4.37	$ 4.37

Note 12 - Stockholders' (Defi_5

Note 12 - Stockholders' (Deficit) - Warrants (Details) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 30, 2016
Number outstanding (in shares)	22,020,000	27,020,000	27,860,000
Weighted average remaining contractual life (Year)	1 year 21 days	1 year 306 days
Weighted average exercise price (in dollars per share)	$ 0.45	$ 0.42
Class of Warrant or Right, Exercisable (in shares)	22,020,000	27,020,000
Warrants exercisable, weighted average exercise price (in dollars per share)	$ 0.45	$ 0.42
Minimum [Member]
Range of exercise price (in dollars per share)	0.25	0.25
Maximum [Member]
Range of exercise price (in dollars per share)	$ 0.60	$ 0.60

Note 12 - Stockholders' (Defi_6

Note 12 - Stockholders' (Deficit) - Warrants Activity (Details) - shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Balance (in shares)	27,020,000
Issued (in shares)	0	0
Class of Warrant or Right, Exercised During Period	(4,000,000)	0
Expired/forfeited (in shares)	(1,000,000)	(840,000)
Balance (in shares)	22,020,000	27,020,000
Warrants exercisable at December 31, 2018 (in shares)	22,020,000	27,020,000

Note 12 - Stockholders' (Defi_7

Note 12 - Stockholders' (Deficit) - Accumulated Other Comprehensive Gain (Loss) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Balance	$ (17,193,058)	$ (21,127,798)
Balance	(11,683,904)	(17,193,058)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Balance	(397,237)	(410,505)
Activity	(39,268)	13,268
Balance	(436,505)	(397,237)
AOCI Attributable to Parent [Member]
Balance	(397,237)	(410,505)
Activity	(39,268)	13,268
Balance	$ (436,505)	$ (397,237)

Note 13 - Employee Equity Inc_3

Note 13 - Employee Equity Incentive Plans (Details Textual) - USD ($)	Dec. 31, 2018	Oct. 28, 2018	Sep. 06, 2018	Sep. 29, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jun. 16, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	2,570,000				2,570,000	5,275,000	1,225,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period					300,000	300,000
Proceeds from Stock Options Exercised					$ 45,000	$ 35,250
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense					$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 0.23	$ 0.21
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$ 267,766				$ 267,766
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition					1 year 321 days
Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				100,000
Chief Operating Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		34,175
Restricted Stock [Member] | Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technology Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	600,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			900,000
Restricted Stock [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			225,000
Restricted Stock [Member] | Board of Director One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			200,000
Restricted Stock [Member] | Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			225,000
Restricted Stock [Member] | Chief Operating Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			225,000
Restricted Stock [Member] | Chief Technology Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			225,000
Restricted Stock [Member] | Board of Director Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			200,000
Restricted Stock [Member] | Board of Director Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			200,000
Restricted Stock [Member] | Board of Director Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			200,000
Restricted Stock [Member] | Board of Director Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	75,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			200,000
The 2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	11,025,000				11,025,000			10,000,000
Common Stock Available for Issuance Increasing Period					9 years
Common Stock Available for Issuance, Annual Increase Percent					5.00%
Common Stock, Capital Shares Reserved for Future Issuance	11,025,000				11,025,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					5 years
Share-based Compensation Arrangement, Restricted Shares Granted to Employees, Number of Installments in Which Restrictions Lapse					3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	2,395,000				2,395,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period					100,000
The 2016 Plan [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period					1 year
The 2016 Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement, Installments for Vesting					2
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	7,605,000				7,605,000
The 2016 Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period					925,000
The 2016 Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					10 years
RSAs [Member] | Restricted Stock [Member] | Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technology Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance			$ 0.33
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Subject to Individual Performance			75,000
Share-based Compensation Arrangement by Share-based Payment Award, Minimum Revenues to be Recognized			$ 30,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Minimum EBITDA to be Recognized			$ 6,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issubable upon Milestones Achieved			75,000
Share-based Compensation Arrangement by Share-based Payment Award, Minimum Revenues to be Recognized for Additional Shares			$ 32,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Minimum EBITDA to be Recognized for Additional Shares			$ 7,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Issubable upon Milestones Achieved			75,000
RSAs [Member] | Restricted Stock [Member] | Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance			$ 0.33
Share-based Compensation Arrangement by Share-based Payment Award, Minimum Revenues to be Recognized			$ 30,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Minimum EBITDA to be Recognized			$ 6,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issubable upon Milestones Achieved			75,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant For Each Recipient			200,000
RSAs [Member] | Maximum [Member] | Restricted Stock [Member] | Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technology Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant For Each Recipient			225,000
Equity Incentive Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	7,500,000				7,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					5 years
Share-based Compensation Arrangement, Installments for Vesting					2
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	0				0
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance	175,000				175,000
Equity Incentive Plan 2009 [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period					1 year
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance	3,876,662				3,876,662
Equity Incentive Plan 2009 [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					10 years

Note 13 - Employee Equity Inc_4

Note 13 - Employee Equity Incentive Plans - Stock Option Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Number of shares (in shares)	5,275,000	1,225,000
Weighted average exercise price (per share) (in dollars per share)	$ 0.26	$ 0.17
Weighted average remaining contractual term (in years) (Year)	3 years 171 days	4 years 32 days	2 years 226 days
Aggregate intrinsic value	$ 16,675	$ 130,475	$ 83,425
Number of shares, granted (in shares)	570,000	4,650,000
Weighted average exercise price (per share), granted (in dollars per share)	$ 0.28	$ 0.26
Number of shares, exercised (in shares)	(300,000)	(300,000)
Weighted average exercise price (per share), exercised (in dollars per share)	$ 0.21	$ 0.13
Number of shares, forfeited/cancelled/expired (in shares)	(2,975,000)	(300,000)
Weighted average exercise price (per share), forfeited/cancelled/expired (in dollars per share)	$ 0.25	$ 0.14
Number of shares (in shares)	2,570,000	5,275,000	1,225,000
Weighted average exercise price (per share) (in dollars per share)	$ 0.28	$ 0.26	$ 0.17
Vested and exercisable at December 31, 2018 (in shares)	887,500
Vested and exercisable at December 31, 2018 (in dollars per share)	$ 0.25
Vested and exercisable at December 31, 2018 (Year)	2 years 335 days
Vested and exercisable at December 31, 2018	$ 14,425

Note 13 - Employee Equity Inc_5

Note 13 - Employee Equity Incentive Plans - Vested Shares (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Number of options vested (in shares)	812,500	62,500
Fair value of options vested	$ 179,978	$ 12,742

Note 13 - Employee Equity Inc_6

Note 13 - Employee Equity Incentive Plans - Stock Options Outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Low price range (in dollars per share)	$ 0	$ 0
High price range (in dollars per share)	$ 0.50	$ 0.50
Outstanding stock options (in shares)	2,570,000	5,275,000
Weighted average remaining contractual life - outstanding (Year)	3 years 171 days	4 years 32 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.28	$ 0.26
Vested stock options (in shares)	887,500	400,000
Weighted average remaining contractual life - vested (Year)	2 years 335 days	1 year 153 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.25	$ 0.19
Range One [Member]
Low price range (in dollars per share)	0	0
High price range (in dollars per share)	$ 0.20	$ 0.20
Outstanding stock options (in shares)	150,000	300,000
Weighted average remaining contractual life - outstanding (Year)	339 days	1 year 339 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.17	$ 0.18
Vested stock options (in shares)	150,000	250,000
Weighted average remaining contractual life - vested (Year)	339 days	1 year 175 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.17	$ 0.17
Range Two [Member]
Low price range (in dollars per share)	0.21	0.21
High price range (in dollars per share)	$ 0.30	$ 0.30
Outstanding stock options (in shares)	1,695,000	4,250,000
Weighted average remaining contractual life - outstanding (Year)	3 years 197 days	4 years 43 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.26	$ 0.25
Vested stock options (in shares)	550,000	150,000
Weighted average remaining contractual life - vested (Year)	3 years 54 days	1 year 109 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.25	$ 0.22
Range Three [Member]
Low price range (in dollars per share)	0.31	0.31
High price range (in dollars per share)	$ 0.50	$ 0.50
Outstanding stock options (in shares)	725,000	725,000
Weighted average remaining contractual life - outstanding (Year)	3 years 299 days	4 years 299 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.34	$ 0.34
Vested stock options (in shares)	187,500	0
Weighted average remaining contractual life - vested (Year)	3 years 299 days	0 years
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.34	$ 0

Note 13 - Employee Equity Inc_7

Note 13 - Employee Equity Incentive Plans - Fair Value Assumptions of Share-based Payments (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Risk-free interest rate	2.91%	1.81%
Expected dividend yield	0.00%	0.00%
Expected volatility	111.00%	127.10%
Expected life of options (Year)	5 years	5 years

Note 13 - Employee Equity Inc_8

Note 13 - Employee Equity Incentive Plans - Weighted Average Grant Date Fair Value Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Stock options granted during the period (in dollars per share)	$ 0.23	$ 0.21
Stock options vested during the period (in dollars per share)	0.22	0.20
Stock options forfeited during the period (in dollars per share)	$ 0.19	$ 0.13

Note 13 - Employee Equity Inc_9

Note 13 - Employee Equity Incentive Plans - Status of Non-vested Shares (Details) - $ / shares	Dec. 31, 2018	Jan. 01, 2018
Shares underlying stock options (in shares)	1,682,500	4,875,000
Weighted average grant date fair value (in dollars per share)	$ 0.24	$ 0.21

Note 14 - Income Taxes (Details

Note 14 - Income Taxes (Details Textual)	12 Months Ended
	Dec. 31, 2018USD ($)
Operating Loss Carryforwards, Total	$ 30,636,792
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (495,005)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability	$ 1,699,440
Revaluation of Deferred Tax Assets (Liabilities) Due to Change in Tax Rate [Member]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (1,699,440)

Note 14 - Income Taxes - Reconc

Note 14 - Income Taxes - Reconciliation of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Federal statutory rate applied to income/(loss) before income taxes	$ 1,058,960	$ 1,117,014
Increase/(decrease) in income taxes results from:
Current tax expense/(benefit)	490,215	1,194
Nondeductible expenses	(582,309)	(44,845)
Change in deferred assets	18,354	(35,423)
Change in valuation allowance	(495,005)	(1,036,746)
Income tax expense/(benefit)	$ 490,215	$ 1,194

Note 14 - Income Taxes - Compon

Note 14 - Income Taxes - Components of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Current tax expense/(benefit)	$ 490,215	$ 1,194
Deferred tax expense/(benefit)	985,220	1,037,940
Change in valuation allowance	(495,005)	(1,036,746)
Total tax expense/(benefit)	490,215	1,194
Bad Debt Allowance [Member]
Deferred tax expense/(benefit)	(6,651)	11,226
Operating Loss Carryforward [Member]
Deferred tax expense/(benefit)	483,302	1,060,942
Amortization of Intangibles [Member]
Deferred tax expense/(benefit)	18,354	5,482
Patent Litigation Settlement [Member]
Deferred tax expense/(benefit)	$ 0	$ (40,904)

Note 14 - Income Taxes - Deferr

Note 14 - Income Taxes - Deferred Income Taxes (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Amortization of intangibles	$ 253,466	$ 261,771
Bad debt allowance	68,133	55,436
Patent litigation liability accrual	359,377	169,709
Impact of the Tax Cuts and Jobs Act	0	(1,699,440)
Operating loss carryforwards	15,585,125	17,973,631
Gross deferred tax assets	16,266,101	16,761,107
Valuation allowance	(16,266,101)	(16,761,107)
Net deferred tax liability/(asset)	$ 0	$ 0

Note 15 - Subsequent Events (De

Note 15 - Subsequent Events (Details Textual) - USD ($)	Dec. 31, 2018	Dec. 27, 2018	Sep. 06, 2018	Mar. 26, 2019	Dec. 31, 2018	Dec. 31, 2017
Class of Warrant or Right, Exercised During Period					(4,000,000)	0
Chief Executive Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			225,000
Chief Financial Officer [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25				$ 0.25
Stock Issued During Period, Shares, Exercise of Warrants	1,000,000
Chief Financial Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			225,000
Chief Technology Officer [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.25
Stock Issued During Period, Shares, Exercise of Warrants		1,000,000
Chief Technology Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			225,000
Chief Operating Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			225,000
Subsequent Event [Member]
Repayments of Lines of Credit				$ 1,400,000
Subsequent Event [Member] | Executive Vice Chairman [Member]
Class of Warrant or Right, Exercised During Period				1,800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.25
Stock Issued During Period, Shares, Exercise of Warrants				1,800,000
Subsequent Event [Member] | Employee [Member]
Class of Warrant or Right, Exercised During Period				1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.25
Stock Issued During Period, Shares, Exercise of Warrants				209,694
Subsequent Event [Member] | Chief Executive Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				225,000
Subsequent Event [Member] | Chief Financial Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				225,000
Subsequent Event [Member] | Chief Technology Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				225,000
Subsequent Event [Member] | Chief Operating Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				225,000